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ABSTRACT 
 This work has focused on improving our knowledge of the thyroid 
specification process. Thyroid cells are derived from mouse embryonic stem cells 
(mESCs) by directed differentiation through multiple intermediate developmental 
stages, including anterior foregut endoderm (AFE), prior to NKX2-1+ thyroid 
progenitor specification. To investigate if transient Nkx2-1 expression can increase 
the efficiency of thyroid specification, we utilized a mESC line double knock-in GFP-
T/hCD4-Foxa2 with a doxycycline inducible (Tet-On) Nkx2-1 transgene. Transient 
activation of the Nkx2-1 transgene at the AFE stage leads to stable induction of high 
levels of endogenous Nkx2-1 as well as early and mature thyroid-specific markers 
including Pax8, Foxe1, Tg, Nis, and Tshr. Lung and neuronal NKX2-1+ lineages were 
not derived in this system. The thyroid progeny mature and organize into follicle-
like structures in 3D culture. These follicles express adherens and tight junction 
proteins indicative of an epithelial character and produce the thyroid hormone 
  vii 
thyroxine (T4) in the presence of iodide. Critical determinants of thyroid lineage 
specification have been revealed by variations in developmental stage timing, 
signaling pathways, and sorting of AFE-stage subpopulations. To provide further 
insights into the mechanisms of thyroid specification, RNA-Seq data acquired from 
relevant stages has identified potential genes involved in early thyroid development. 
The results demonstrate that Nkx2-1 can act as a stage-specific inductive signal 
during directed differentiation of mESCs to thyroid follicular cells. We have also 
developed a mouse model to recapitulate these results in an in vivo context. This 
work has provided novel insights into thyroid specification and provides an efficient 
system for deriving and studying thyroid cells, which can be used for in vitro 
modeling of development and disease. 
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CHAPTER I - GENERAL INTRODUCTION  
Regenerative Medicine 
The field of regenerative medicine seeks to repair or replace non-functional 
cells, tissues, or organs. Although many organs have a substantial intrinsic capability 
to regenerate on their own (liver), others are more limited (heart, pancreas, thyroid, 
and lung), leading to a diverse array of clinical phenotypes.  
Generating cell lineages in vitro from pluripotent stem cells (PSCs) presents 
multiple advantages (Illustration 1.1). First, while specific cell populations at early 
developmental stages can be difficult to isolate in appreciable quantities and some 
mature cell types can be difficult to expand, differentiation protocols can generally 
be easily scaled-up to generate an inexhaustible source of cells useful for many 
types of analyses. Next, cells at every stage are accessible for experimental 
manipulation or characterization, allowing developmental mechanisms to be finely 
studied. PSCs can be genetically modified with altered or corrected genes, 
transgenes, or lineage-specific reporters. Additionally, while many primary cell 
types are terminally differentiated or have limited ex vivo expansion capacity, PSC-
derived lineage progenitors are often more readily expandable. Lastly, the derived 
product can be used to drug testing or disease studies, and has potential to be used 
for cell therapies.  
The convergence of these advances in stem cell biology with the fields of 
tissue engineering, gene delivery systems, and medical devices hold great promise 
for upcoming novel therapeutic treatments.  
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Illustration 1.1. A representation of the flow from PSCs to clinical significance.  
 
 
 
 
Guidance of Cell Fate Decisions through Directed Differentiation 
Directed Differentiation of Pluripotent Stem Cells 
 Protocols for the directed differentiation from PSCs have been developed for 
many cells lineages, representing every germ layer (Gadue et al., 2005; Keller, 2005; 
Murry and Keller, 2008). In vitro models of development using PSCs seek to 
recapitulate the main stages of in vivo development using precise manipulation of 
signaling pathways to guide cell fates through sequential developmental 
intermediates.  
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 The initiation of the directed differentiation field began with the derivation of 
pluripotent ESC lines initially from mouse (Evans and Kaufman, 1981) and then 
from human (Thomson et al., 1998), followed later by induced pluripotent stem cells 
(iPSCs) derived from mouse (Takahashi and Yamanaka, 2006) and human somatic 
cells (Takahashi et al., 2007). These PSCs can be grown in specific culture conditions 
allowing repeated passaging and expansion with maintenance of pluripotency. 
Directed differentiation of mESCs is typically initiated through LIF withdrawal and 
transfer to suspension culture to allow formation of embryoid bodies (EBs). 
Differentiation through EBs spontaneously generates a majority of ectodermal 
lineages, along with a lesser number of mesodermal and endodermal progenitors 
(Doetschman et al., 1985; Itskovitz-Eldor et al., 2000). Directed differentiation to 
DE-derived lineages were highly inefficient until the discovery of Activin A (Activin) 
in 2004 as an endodermal specification signal (D'Amour et al., 2005; Ikonomou and 
Kotton, 2015; Kubo et al., 2004). Despite ongoing advances in directed 
differentiation studies, many differentiation protocols struggle with low efficiency 
and often do not achieve complete maturation to full functionality.  
 
Directed Differentiation to the Thyroid Lineage 
 Early efforts with directed differentiation to thyroid relied on endoderm 
progenitors generated through differentiating EBs (Arufe et al., 2006; Jiang et al., 
2010; R.-Y. Lin et al., 2003). Endoderm induction signaling was absent in these 
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protocols, and instead TSH was added to stimulate development and growth. This 
developmental mechanism is unclear since, in the mouse embryo, TSH is not 
expressed in until E12.5 (S. C. Lin et al., 1994) and TSHR is not expressed until E15 
(Postiglione et al., 2002), indicating normal early thyroid specification and 
development proceeds independently of TSH signaling, confirmed by normal 
thyroid development in the TSHR null mouse (Marians et al., 2002). A later study 
demonstrated the effectiveness of endoderm induction through Activin without TSH 
signaling, but did achieve expression of functional markers such as Tg or Tpo (Ma et 
al., 2009). These early studies suffered from low (or unreported) efficiency and a 
resulting highly heterogeneous final population difficult to characterize. 
Additionally, due to the stochastic nature of endoderm populations derived from EB 
culture, little developmental knowledge of the defined stages and factors required 
for thyroid specification was resolved.  
 Directed differentiation protocols were subsequently developed with more 
of an embryological basis, including endoderm induction with Activin, specific 
endoderm patterning, and careful analysis of specification factors. In 2012, a study 
was published on the derivation of NKX2-1+ lung and thyroid progenitors, using an 
Nkx2-1GFP reporter line to isolate these endodermal lineage progenitors at early 
stages (Figure 1.1A,B) (Longmire et al., 2012). At this time, it was unknown what the 
ratio was of lung or thyroid derived from these methods, and if there existed a 
bipotent progenitor or two independently specified lineage progenitors. A follow-up 
study resolved the unique specification to thyroid progenitors (Figure 1.1C) and 
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demonstrated functionality by transplantation and rescue of thyroid-ablated mice 
(Kurmann et al., 2015). While effective, the progenitor yield remained low and 
relied on purification through knock-in fluorescent reporters. Additionally, despite 
successes in the mouse system, these findings have yet to be robustly and 
reproducibly repeated in human PSCs (Kurmann et al., 2015), demonstrating a need 
for additional developmental knowledge in this area. 
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Figure 1.1. Previous published work using directed differentiation to thyroid. 
A. Sort schematic to purify Nkx2-1GFP –Lung/Thyroid progenitors. 
B. Gene expression analysis showing upregulation of both lung and thyroid markers. 
A,B from: Efficient Derivation of Purified Lung and Thyroid Progenitors from Embryonic Stem Cells 
(Longmire et al., 2012)  
C. Flow cytometry schematic showing the derivation of the NKX2-1+, PAX8+ thyroid population. 
D. Gene expression analysis for sorted populations from (C). 
C,D from: Regeneration of Thyroid Function by Transplantation of Differentiated Pluripotent Stem 
Cells (Kurmann et al., 2015)  
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Transcriptional Manipulation of Cell Fate Decisions 
Transcription Factors in Cellular Identity 
Every cell lineage, including transcription factors, expresses a distinct gene 
expression profile. In many cell types, either a single TF or a core network of TFs 
have been identified that regulate a host of downstream targets critical for 
establishing and maintaining cellular identity. A singular TF that seemingly acts as a 
lineage determinant signal has been termed a “master regulator” (S. S.-K. Chan and 
Kyba, 2013; Elcheva et al., 2014; Lewis, 1992; Whyte et al., 2013). Many have been 
discovered through knock-out developmental models which have shown the 
inability of a cell type or organ to develop in the absence of a critical gene. These 
genes, such as the Foxa (Friedman and Kaestner, 2006), Gata (Lentjes et al., 2016), 
and Hox (Mallo and Alonso, 2013) families of genes, have critical roles both in 
transient developmental populations, as well as in the identity of adult or terminally 
differentiated populations. These transcription factors have been key targets for 
researchers for determining cellular identification based on gene or protein 
expression and more recently for manipulating cell fate.  
Manipulating Cell Fate through Transcriptional Expression 
Cell fate is established over the course of development or from adult 
progenitor populations. This flow of fate acquisition was long thought to be 
unidirectional and irreversible. However, research in recent decades had discovered 
the plasticity of specified lineages and developed methods to manipulate cell fate. 
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The first studies to demonstrate the magnitude of cellular plasticity used nuclear 
transfer in Xenopus (Gurdon et al., 1958) and sheep (Campbell et al., 1996). Since 
the early findings, genetic engineering technologies have greatly advanced and 
researchers have developed a variety of strategies to alter cell fate. 
Transcriptional programming is a strategy to convert cell fate by 
manipulating internal cell signaling to override the existing cellular identity and 
establish an alternative cell fate. This has been shown to be an effective method of 
deriving specific populations of cells that may be difficult to isolate, expand, or 
derive through primary cell culture or through directed differentiation. Lineages of 
all germ layers have been represented by such studies including to and from 
somatic or pluripotent stages, demonstrating the broad applications of 
transcriptional overexpression studies (Illustration 1.2).  
 
Illustration 1.2. An overview of transcriptional overexpression systems.  
From: Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration (Jopling 
et al., 2011) 
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In the next four sections, there follows brief overviews of three of the main 
categories of lineage specification through transcription expression 
(transdifferentiation, reprogramming, and direct reprogramming) followed by a 
more in-depth review of forward programming. 
Transdifferentiation of Somatic Cells (Direct Conversion) 
Using the concept of the “master regulator” genes, researchers have been 
able to successfully convert multiple adult cell types to many other lineages 
(Illustration 1.2) (Prasad et al., 2016; J. Xu et al., 2015). This process entails the 
forced expression of one or multiple transcription factors in a somatic cell type that 
results in the conversion to an alternate lineage without progression through a 
pluripotent or multipotent stage. The first instance was the discovery of a single 
transcription factor, MyoD, that was able to convert fibroblasts into muscle cells 
(Davis et al., 1987). Since then, the abilities of other transcription factors to convert 
cell lineages in vitro have been discovered. 
The derivation of specific lineages has often required a combination of select 
transcription factors, for example the use of Gata4, Mef2c, and Tbx5 to convert 
fibroblasts to cardiomyocytes (Ieda et al., 2010). The candidate cell type of origin for 
many studies has often been a closely related lineage, for example, adult pancreatic 
exocrine cells to beta-cells (Zhou et al., 2008), astrocytes into GABAergic neurons 
(Heinrich et al., 2010), and B cells to macrophages (Bussmann et al., 2009). Many 
studies have also shown reprogramming can be accomplished within germ layer of 
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origin, for example, fibroblasts to cardiomyocytes (Ieda et al., 2010; K. Song et al., 
2012), myoblasts to adipocytes (Kajimura et al., 2009), fibroblasts to chondrocytes 
(Hiramatsu et al., 2011), and others. Reprogramming has also been accomplished 
across germ layer of origin, for example, fibroblasts to neurons (Vierbuchen et al., 
2010), fibroblasts to hepatocytes (Y. Du et al., 2014; P. Huang et al., 2011; 2014), 
fibroblasts to thymic epithelium (Bredenkamp et al., 2014), and hepatocytes to 
neurons (Marro et al., 2011), showing the strength of the lineage conversion signals.  
Interestingly, while multiple studies have shown similar results with their 
reprogramming strategies, often the combination of induced transcription factors 
varies, for example cardiomyocytes can be reprogrammed from fibroblasts using 
Gata4, Hand2, Mef2c, Tbx5 (K. Song et al., 2012), Gata4, Mef2c, Tbx5 (Ieda et al., 
2010), Hand2, Nkx2.5, Gata4, Mef2c, Tbx5 (Addis et al., 2013), Mef2c, Myocd, Tbx5 
(Protze et al., 2012), Myocd, Srf, Mesp1, Gata4, Tbx5, Mef2c, Smarcd3 (Christoforou 
et al., 2013), indicating multiple approaches are possible to stabilize gene networks, 
albeit with variations in efficiency and maturation potential. A number of these 
studies have similarly been performed in vivo using the mouse model to generate 
cardiomyocytes (Ieda et al., 2010; K. Song et al., 2012), hepatocytes (G. Song et al., 
2016), and pancreatic β cells (Zhou et al., 2008), among others, which could have 
direct implications for regenerative medicine therapies.  
While challenges remain with complete transcriptional downregulation of 
the parent population profile as well as attaining full functional maturation (J. Xu et 
al., 2015), a great number of successes and advancements have been achieved with 
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this approach, and these have been applied to the subsequently developed following 
approaches. 
 
Illustration 1.3. A summary of the lineages derived from transdifferentiation studies.  
From https://www.systembio.com/stem-cell-research/transdifferentiation-factors/overview 
  
Reprogramming to Pluripotency 
The landmark paper by Takahashi and Yamanaka (Takahashi and Yamanaka, 
2006) opened up entirely new areas with their finding that somatic cells can be 
converted to a pluripotent stage generating non-embryonic sources of pluripotent 
cells. The cooperative actions of the core pluripotency transcription factors have 
been well-characterized and exemplify how cellular identity can be maintained by a 
stable transcriptional network that, in this case, serves to both maintain 
pluripotency and suppress differentiation-associated genes. 
Since the initial publication, other methods for pluripotency reprogramming 
have also been described (Yamanaka and Blau, 2010), including non-integrative 
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methods (Schlaeger et al., 2015), with similar results. This seminal work not only 
gave major insights into the plasticity of cell fate but also presented new 
opportunities in stem cell research. With iPSC technology, researchers have been 
able to relatively easily derive more lines, including patient-specific lines. These 
lines have enabled research for disease-modeling of many human genetic diseases, 
both in studying the differentiation abilities and mature phenotypes of iPSC-derived 
cells. In addition, recent advances in genetic engineering (TALENs, followed by 
Crispr/Cas9), which have replaced more laborious techniques and add specificity, 
have merged with the stem cell field to greatly facilitate the generation of modified 
cells lines. There are a couple types of particular interest and relevance. Reporter 
cell lines have been engineered to track and purify differentiating populations 
expressing lineage-specific markers. Disease-specific lines can also be genetically 
corrected and differentiated in parallel for powerful disease modeling opportunities 
with isogeneic lines, which often present themselves as the logical next steps for 
many research laboratories.  
Direct Reprogramming through Unstable Intermediates 
Merging the concepts of reprogramming with rewinding cell fate toward 
pluripotency has created a hybrid method for switching cell fate that avoids the 
risks associated with pluripotency, such as of tumor formation, and often starts with 
an expandable and accessible cell type. Studies have discovered that by transiently 
overexpressing the pluripotency transcription factors, they can create an unstable 
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intermediate more susceptible to subsequent alternative lineage-specific signals. 
This unstable intermediate is subsequently re-specified into the target cell type 
using target lineage specification signals. This has been successful for a number of 
lineage conversions, such as fibroblasts to blood progenitors (Szabo et al., 2010), 
cardiomyocytes (Efe et al., 2011), hyaline cartilage (Hiramatsu et al., 2011), neural 
progenitors (J. Kim et al., 2011), angioblasts (Kurian et al., 2013), endothelial cells 
(Li et al., 2013), smooth muscle cells from embryonic lung fibroblasts (Karamariti et 
al., 2013), and neural progenitors from cells isolated from human urine (L. Wang et 
al., 2013). This method of using brief destabilization through pluripotency-
associated TFs may minimize the requirement for the lineage-specification signals 
to also down-regulate the existing cell fate transcriptional networks. Despite novel 
findings and relative rapid cell fate conversion, the intermediate cell fates have not 
been well characterized and their derivation may need to be highly variable 
depending on the initial and desired cell types.  
Forward Programming of Differentiating PSCs 
Transcriptional overexpression has also proved to be a useful means of 
directing cell fate using pluripotent stem cells, both in the undifferentiated state and 
in various stages of differentiation, termed forward programming (Illustration 1.4) 
(Belian et al., 2015; David et al., 2009). This strategy is unique in its targeting of 
uncommitted cell types, while the previously addressed methods require 
transcriptional overexpression to both disrupt existing transcriptional networks 
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and establish new ones, in either a one step process (transdifferentiation) or a two-
step process (direct reprogramming).  
 
 Illustration 1.4. Lineages specified from transcriptional factor overexpression in ES systems. 
From: Forcing cells to change lineages. (Graf and Enver, 2009) 
 
Several parameters can dramatically affect downstream results in this 
dynamic system. These include the stage, length, level, and context of induction. 
Generally speaking, most forward programming studies have overexpressed a 
transcription factor of interest in media or during the course of a directed 
differentiation protocol known to promote the specification of the lineage of 
interest. Because few differentiation strategies result in a high percentage of the 
lineage of interest, these studies generally report a dramatic comparative increase 
in the percentage of the derived lineage. This method of forward programming from 
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PSC starting material not only allows high-percentage specification of clinically 
relevant populations but also helps resolve important developmental intermediates.  
A number of studies have used a constitutive inducible construct, permitting 
overexpression targeted at specific developmental stages. A number of studies have 
targeted the pluripotent stage for overexpression of their lineage specification 
signals. This strategy has been notably successful in deriving lineages of ectodermal 
origin, such as neurons (Dandapat et al., 2013; Z.-W. Du et al., 2006; Pang et al., 
2011; Sun et al., 2016; Velkey and O'Shea, 2013; Y. Zhang et al., 2013) as well as 
extraembryonic lineages (Fujikura et al., 2002; C. Zhang et al., 2007). For 
specification of mesodermal lineages, transcription expression in PSCs has shown 
success in the generation of multiple lineages. Usage of inducible systems (Tet-
On/Off) has allowed for stage-specific induction, such as overexpression in 
differentiating EBs or mesodermal stage. Studies using this technology allow for 
more refined analysis of stage-specific competence of intermediate populations. 
This has been used in studies successfully deriving cardiomyocytes (Behrens et al., 
2013; Bondue et al., 2008; Turbendian et al., 2013) hematopoietic progenitors (Dai 
et al., 2006; Iacovino et al., 2009; Ismailoglu et al., 2008; Matsumoto et al., 2006), 
myogenic progenitors (Darabi et al., 2008), as well as adipocytes and osteoblasts 
(Tashiro et al., 2009). Specific endoderm lineages, as well as endoderm itself 
(Holtzinger et al., 2010; Levinson-Dushnik and Benvenisty, 1997; Lim et al., 2009), 
have also been derived through transcriptional overexpression. Also, success has 
been reported from induction in PSCs to derive pancreatic progenitors (Blyszczuk et 
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al., 2003; Liew et al., 2008; Shiroi et al., 2005), thyrocytes (Ma et al., 2013), and 
hepatocytes (Kuai et al., 2006). Studies using inducible constructs have been more 
developmentally informative and many have shown stage-specific effects. Inducible 
expression beginning at the endodermal stage has also been used to derive 
pancreatic lineage (Bernardo et al., 2009; Kubo et al., 2011; Treff et al., 2006) and 
hepatocytes (Kubo et al., 2010). More so, two studies used induction from a 
patterned endoderm stage (Gage et al., 2014; Serafimidis et al., 2008) to derive 
pancreatic lineages, further demonstrating the need to identify and target 
developmentally intermediate populations with maximum competence.  
Transcription factors often have roles in multiple lineages and, over the 
course of development, the epigenetic landscape changes to expose various 
transcription targets involved in different lineage specification processes. So, as an 
example of the critical nature of the induction timing, a few studies have 
demonstrated the derivation of alternative lineages based on induction timing. 
Wang and colleagues reported Fezf2 induction in EBs resulted in the derivation of 
rostral forebrain progenitors, while induction of the same gene at the neural 
progenitor stage derived dorsal telencephalic progenitors and cortical neurons (Z.-
B. Wang et al., 2011). Additionally, Chan and colleagues reported that induction of 
Mesp1 in early mesoderm led to derivation of hematopoietic progenitors, while 
induction in late mesoderm led to either cardiac or skeletal myogenic precursors, 
further depending on the presence of serum in the media (S. S.-K. Chan et al., 2016; 
2013).  
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Other studies have developed a variety of strategies to target PSC-derived 
specified lineage progenitors for overexpression to enhance the generation of 
specific downstream lineages. For example, differentiated neural progenitors have 
further specified into cortical interneurons (Petros et al., 2013) or oligodendrocytes 
(Z.-W. Du et al., 2006), following overexpression of Nkx2-1 or Olig2, respectively. 
Also, Takacs and colleagues reported enhanced maturation of dendritic cells 
following overexpression of Runx3 in myeloid progenitors (Takacs et al., 2017). An 
incremental approach has also been demonstrated in the liver system, with 
stepwise transcriptional overexpression used to specify cells to endoderm, further 
to hepatoblasts, and then for maturation with a single transcription factor induced 
to progress to each stage (Takayama et al., 2012a). Conversely to inducing 
maturation, other studies have maintained an expandable progenitor stage, 
hematopoietic (Gandillet et al., 2009; Richter et al., 2006; Serrano et al., 2010) or 
megakaryocyte (Nakamura et al., 2014). These studies show that transcriptional 
overexpression can be used for fine-tuned manipulation of precise specification 
stages.  
As well as the timing of induction, nearly all forward programming studies 
continue to induce, expand, and mature their cultures in media containing lineage 
specification or growth promoting signals, i.e. growth factors and other signaling 
molecules, and often these studies specifically report the necessity of accompanying 
signaling factors on cell fate induction. In some studies, signaling context has even 
led to differential fate outcomes, such as Mesp1 overexpression in the derivation of 
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cardiac versus skeletal muscle precursors in the presence of absence of serum (S. S.-
K. Chan et al., 2013) and Eomes overexpression in the derivation of cardiac 
mesoderm or endoderm in low or high Activin, respectively (van den Ameele et al., 
2012). 
Interestingly, multiple studies often report their success of different 
transcription factors in the specification of the same lineage. For example, Hoxb4 
(Kyba et al., 2002), as well as Hoxa4, Hoxc4, or Hoxd4 (Iacovino et al., 2009), Stat5 
(Kyba et al., 2003), c-Myb (Dai et al., 2006), Scl (Ismailoglu et al., 2008), Klf6 
(Matsumoto et al., 2006), Etv and Gata2 (Koyano-Nakagawa et al., 2012), Lhx2 (Dahl 
et al., 2008; Kitajima et al., 2011), Mesp1 (S. S.-K. Chan et al., 2013) have all been 
implicated in the enhancement of the hematopoietic lineage. Likewise, Mesp1 
(Bondue et al., 2008; Lindsley et al., 2008), Nkx2-5 (David et al., 2009), Gata4, Gata5, 
or Gata6 (Turbendian et al., 2013), and Rbm24 (T. Zhang et al., 2016) have 
reportedly led to enhancement of a cardiomyocyte fate. Even for an endodermal 
lineage, multiple transcription factors have been reported to enhance derivation of 
pancreatic lineages including Pax4 (Blyszczuk et al., 2003), Ngn3 (Treff et al., 2006), 
Ngn2, Pdx1 (Kubo et al., 2011; Miyazaki et al., 2004; Vincent and Odorico, 2009). 
This variety of approaches indicates flexibility in the transcriptional initiation of 
lineage establishment. 
Taken together, these studies show the inductive effect of transcriptional 
expression is often highly dependent on parameters such as stage and context. This 
approach can be used in a variety of ways to direct cell fate toward intermediate or 
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final lineages at high efficiency and to resolve progenitor stages and developmental 
competence.  
 
Forward Reprogramming to Thyrocytes 
A few studies have previously examined the effects of transcriptional 
overexpression on the derivation of thyrocytes in PSC systems. The first report used 
inducible overexpression of both Nkx2-1 and Pax8 in differentiating EBs (Antonica 
et al., 2012). This study reported success in deriving thyrocytes with dual induction 
of these factors, but did not use endoderm induction (Activin) or growth factors for 
thyroid-specification (as they were unknown at this time), instead relying on early 
TSH signaling and Matrigel culture. A later study also demonstrated the 
effectiveness of dual Nkx2-1 and Pax8 overexpression in mouse thyrocyte 
derivation (Ma et al., 2013) followed by human thyrocyte derivation (Ma et al., 
2015a). While these studies did enhance their results through endoderm induction 
with Activin, their use of constitutive constructs creates difficulties in resolving 
developmental importance. Additionally, both studies reported very low efficiency 
of thyroid derivation with either factor alone. From these studies, there remains a 
need for research using a development-based approach relying on recent 
knowledge of signaling pathways critical for thyroid-specific development to 
interrogate stage-specific competence and developmental mechanisms, which is the 
basis for this body of work. 
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Table 1.1. An overview of forward programming studies and strategies. 
 
Origin Induced Stage Technology Target Lineage 
Induced 
Factor(s) 
Reference 
hPSC PSC 
Lentiviral Vector 
transduction (TetO) 
Neurons 
Brn2, Ascl1, 
Myt1l 
(Pang et al., 2011) 
hPSC PSC 
Lentiviral Vector 
transduction (TetO) 
Neurons 
Ngn2 or 
NeuroD1 
(Y. Zhang et al., 2013) 
mESC EB Tet-On (Kyba) Neural Progenitors Ngn1 
(Velkey and O'Shea, 
2013) 
mESC EB Tet-On (Kyba) Neural Progenitors Dux4 (Dandapat et al., 2013) 
mESC 
D5 neural 
progenitors 
Tet-On (Kyba) Cortical Interneurons Nkx2-1 (Petros et al., 2013) 
mESC 
Neural 
Progenitors 
Tet-On (Kyba) Oligodendrocytes Olig2 (Z.-W. Du et al., 2006) 
ESC ESC Tet-On (Kyba) Neurons Gmnn 
(Yellajoshyula et al., 
2011) 
hPSC PSC 
Lentiviral Vector 
transduction (TetO) 
GABAergic Neurons 
ASCLSA, LHX6, 
DLX2, 
miR-9/9*-124 
(Sun et al., 2016) 
mESC 
EB 
Tet-On (Kyba) 
Rostral forebrain 
progenitors 
Fezf2 
(Z.-B. Wang et al., 
2011) Neural 
Progenitor 
dorsal telencephalic 
progenitors, cortical 
neurons 
mESC PSC Tet-On (Kyba) Glutamatergic Neurons Ngn1 (Reyes et al., 2008) 
mESC EB Tet-On (Kyba) Motor neurons Ngn2, Isl1, Lhx3 (Mazzoni et al., 2013) 
hPSC PSC OPTi-OX 
Neurons  NGN2 
(Pawlowski et al., 
2017) 
Myocytes MYOD1 
Oligodendrocytes OLIG2, SOX10 
mESC EB Tet-On (Kyba) Sensory hair cells 
Gfi1, Pou4f3, 
Atoh1 
(Costa et al., 2015) 
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mESC EB Tet-On (Kyba) Cardiovascular Progenitor Mesp1 (Bondue et al., 2008) 
mESC EB Tet-On (Kyba) Cardiovascular Progenitor Mesp1 (Lindsley et al., 2008) 
mESC ESC 
Stable Clone, Vector 
electroporation 
Cardiac progenitors Nkx2-5 (David et al., 2009) 
mESC EB (Mesoderm) Tet-On (Kyba) Cardiac suppression Hoxa10 (Behrens et al., 2013) 
mESC ESC Tet-On (Kyba) Cardiomyocytes Rbm24 (T. Zhang et al., 2016) 
mESC EB (Mesoderm) Tet-On (Kyba) Cardiomyocytes 
Gata4 or Gata5 
or Gata6 
(Turbendian et al., 
2013) 
mESC 
Day 2 
monolayer 
Tet-On (Kyba) 
Cardiac mesoderm 
Eomes (low 
Activin) (van den Ameele et al., 
2012) 
Endoderm 
Eomes (high 
Activin) 
mESC 
Primitive 
Hematopoietic 
Progenitor 
Tet-On (Kyba) Definitive HSCs HoxB4 (Kyba et al., 2002) 
mESC EB / Mesoderm Tet-On (Kyba) Hematopoietic progenitors 
Hoxa4, Hoxb4, 
Hoxc4, or Hoxd4 
(Iacovino et al., 2009) 
Later studies resolving the role of Hoxb4 on hematopoietic derivation in mouse or human PSCs: (Pilat et al., 2005) (Bowles et al., 
2006) (S.-J. Lu et al., 2007) (Unger et al., 2008) (Lee et al., 2008) (K.-M. Chan et al., 2008) (Tashiro et al., 2012) (Jackson et al., 
2016) 
mESC EB Tet-On (Kyba) Hematopoietic Stat5 (Kyba et al., 2003) 
mESC EB / Mesoderm Tet-On (Kyba) 
Endothelial Hoxa3 
(Iacovino et al., 2011b) 
Hematopoietic Runx1 
mESC Mesoderm Tet-Off Hematopoietic progenitors c-Myb (Dai et al., 2006) 
mESC 
EB (Early 
mesoderm) 
Tet-On (Kyba) Hematopoietic progenitors Scl 
(Ismailoglu et al., 
2008) 
mESC EB Tet-On (Kyba) 
Hematopoietic Scl 
(Chao et al., 2015) Megakaryocytes Erg or Fli1 
Erythrocytes Klf1 
mESC PSC Retroviral infection Hematopoietic Oct4 
(Camara-Clayette et al., 
2006) 
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mESC EB Tet-On (Kyba) Hematopoietic Klf6 
(Matsumoto et al., 
2006) 
mESC Hemangio-blast Tet-On (Kyba) Hematopoietic AP-1 Inhibition (Obier et al., 2016) 
mESC 
D5 myeloid 
progenitors 
Tet-On (Kyba) 
Enhanced maturation of 
dendritic cells 
Runx3 (Takacs et al., 2017) 
mESC EB Tet-On (Kyba) Hemangioblast Gata2 (Lugus et al., 2007) 
mESC 
Hematopoietic 
Progenitors  
Tet-On (Kyba) Progenitor maintenance 
Sox7 (Gandillet et al., 2009) 
Sox18 (Serrano et al., 2010) 
mESC 
Hematopoietic 
Progenitors  
Tet-On (Kyba) Hematopoietic stem cell Lhx2 (Richter et al., 2006) 
mESC PSC Vector electroporation Hematopoietic progenitors Stat5A (Schuringa et al., 2004) 
mESC EB Tet-On (Kyba) Hematopoietic progenitors Cdx4 (Davidson et al., 2003) 
mESC EB Tet-On (Kyba) Hematopoietic Cdx4 (Y. Wang et al., 2005) 
mESC 
EB 
Tet-On (Kyba) 
Hematopoietic progenitors Cdx1 or Cdx4 
(McKinney-Freeman et 
al., 2008) 
Hematopoietic 
Progenitors  
Hematopoietic 
differentiation 
Cdx4 
mESC EB Tet-On (Kyba) 
Hematoendothelial 
progenitors 
Etv2, Gata2 
(Koyano-Nakagawa et 
al., 2012) 
mESC Mesoderm 
Retroviral transduction 
Hematopoietic progenitors Lhx2 
(Kitajima et al., 2011)  
Tet-On (Kyba) 
(Kitajima et al., 2013) 
(Kitajima et al., 2015)  
mESC 
Early 
mesoderm 
Tet-On (Kyba) 
Hematopoietic progenitors Mesp1 (+Serum) (S. S.-K. Chan et al., 
2013) (S. S.-K. Chan et 
al., 2016) 
 
Late Mesoderm Cardiac precursors Mesp1 (+Serum) 
Late Mesoderm 
Skeletal myogenic 
precursors 
Mesp1 
(-Serum) 
mESC ESC Tet-On (Kyba) 
FLK1+, endothelial, 
hematopoietic 
Ovol2 (J. Y. Kim et al., 2014) 
mESC ES or EB Tet-On (Kyba) 
Inhibition of 
hematopoiesis 
Foxf1 (Fleury et al., 2015) 
mESC EB Tet-On (Kyba) Hematopoietic progenitors Lhx2 (Dahl et al., 2008) 
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mESC EB Tet-On (Kyba) 
mesodermal, 
hemangioblastic, and 
hematopoietic progenitors 
Mixl1 (Willey et al., 2006) 
mESC EB Tet-On (Kyba) Erythrocytes EKlf (Frontelo et al., 2007) 
hPSC 
Megakaryocyte 
Progenitor 
Tet-On 
Expandable 
megakaryocyte lines 
c-MYC, BMI1 
(Nakamura et al., 
2014) 
hPSC PSC 
Lentiviral Vector 
transduction 
Hematopoietic progenitors HOXA9 
(Ramos-Mejía et al., 
2014) 
hPSC PSC 
Lentiviral Vector 
transduction 
Pan-myeloid 
hematopoietic progenitors 
GATA2, ETV2 
 
(Elcheva et al., 2014) 
erythro-megakaryocytic  
hematopoietic progenitors 
GATA2, TAL1 
mESC 
D5.25 Flk1+ 
mesoderm 
Tet-On (Kyba) 
Haemogenic endothelial 
progenitors 
Sox17 (Clarke et al., 2013) 
mESC 
Mesoderm or 
Hemogenic 
endothelium 
Tet-On (Kyba) 
Definitive hematopoietic 
cells 
Endoglin (Nasrallah et al., 2015) 
mESC EB Tet-On (Kyba) 
Megakaryocyte-erythroid 
progenitors  
Gata1 (Noh et al., 2015) 
hPSCs PSC 
Lentiviral Vector 
transduction 
Megakaryocytes 
GATA1, FLI1, 
TAL1 
(Moreau et al., 2016) 
hPSC 
Myeloid-
restricted 
precursors 
Lentiviral Vector 
transduction (TetO) 
Self-renewing multi-
lineage HSPCs 
HOXA9, ERG, 
and RORA 
(Doulatov et al., 2013) 
mESC EB Tet-On (Kyba) Myogenic progenitors Pax3 (Darabi et al., 2008)  
mESC EB Tet-On (Kyba) Myogenic progenitors Pax7 (Darabi et al., 2011) 
hPSC EB 
Lentiviral Vector 
transduction (TetO) 
Myogenic progenitors Pax7 (Darabi et al., 2012) 
mESC EB Tet-On (Kyba) Paraxial mesoderm Pax3 (Magli et al., 2013) 
miPSC EB Adenovirus transduction 
adipocyte PPARɣ 
(Tashiro et al., 2009) 
osteoblast Runx2 
mESC PSC Tet-On (Kyba) Mesendoderm Tbx3 (Weidgang et al., 2013) 
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mESC EB Tet-On (Kyba) Endoderm Gata4 
(Holtzinger et al., 
2010) 
mESC PSC 
Episomal plasmid 
supertransfection 
Extraembryonic endoderm Gata4 or Gata6 (Fujikura et al., 2002) 
mESC PSC 
Episomal plasmid 
supertransfection 
Extraembryonic endoderm 
Gata1 or Gata2 
or Gata3 
(C. Zhang et al., 2007) 
mESC PSC Vector electroporation Endoderm Foxa2 
(Levinson-Dushnik 
and Benvenisty, 1997) 
mESC PSC 
Tet-on targeted 
transgene 
Extraembryonic endoderm SOX17 (Niakan et al., 2010) 
hPSC PSC 
Transgene integration 
(pClip), inducible 
Definitive Endoderm SOX7 
(Séguin et al., 2008) 
Extraembryonic endoderm SOX17 
mESC PSC Vector electroporation Endoderm Mixl1 (Lim et al., 2009) 
mESC EB Tet-On (Kyba) Thyrocytes Nkx2-1, Pax8 (Antonica et al., 2012) 
mESC Constitutive 
(PSC through 
endoderm) 
Retroviral vector 
electroporation 
Thyrocytes Nkx2-1, Pax8 
(Ma et al., 2013) 
miPS (Ma et al., 2015b) 
hPSC (Ma et al., 2015a) 
mESC ES Plasmid transfection Hepatocytes Hnf4 (Kuai et al., 2006) 
mESC Endoderm Tet-On (Kyba) Hepatocytes Hhex (Kubo et al., 2010) 
hPSC Endoderm 
Vector transduction 
(constitutive) 
Hepatocytes HEX (Inamura et al., 2011) 
hPSC 
Primitive 
endoderm 
Adenovirus vector 
transduction 
Extra-embryonic 
endoderm SOX17 
(Takayama et al., 
2011) 
Mesendoderm Anterior DE 
hPSC 
Mesendoderm Adenovirus vector 
transduction 
Hepatocytes 
FOXA2 (Takayama et al., 
2012b) DE HNF1a 
hPSC 
Mesendoderm 
Adenovirus vector 
transduction 
Hepatocytes 
FOXA2 
(Takayama et al., 
2012a) 
DE HNF1a 
hepatoblast HNF4a 
mESC ES Plasmid transfection Pancreatic endocrine Nkx2-2 (Shiroi et al., 2005) 
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mESC 
Retinoic Acid 
patterned 
endoderm 
Plasmid electroporation 
(Tet-On) 
Pancreatic endocrine Ngn3 
(Serafimidis et al., 
2008) 
hPSC PSC Vector transfection Pancreatic PDX1 (Lavon et al., 2006) 
mESC Endoderm Tet-On (Kyba) Pancreatic endocrine Ngn3 (Treff et al., 2006) 
mESC EB Plasmid electroporation Pancreatic endocrine Pax4 (H.-T. Lin et al., 2007) 
hPSC PSC Plasmid transfection β-islet cells Pax4 (Liew et al., 2008) 
hPSC 
Foregut 
endoderm 
Adenovirus transfection β-islet cells Pax4 (Gage et al., 2014) 
mESC ES Plasmid electroporation β-islet cells Pax4 (Blyszczuk et al., 2003) 
mESC EB Tet-On (Kyba) Pancreatic endocrine Ngn2 or Pdx1 
(Vincent and Odorico, 
2009) 
mESC Plated EBs Tet-On (Kyba) Pancreatic progenitors PTF1a (Nair et al., 2014) 
mESC Endoderm Tet-On (Kyba) β-islet cells Ngn2, Pdx1 (Kubo et al., 2011) 
hPSC EB 
Vector electroporation 
(Tet-Off) 
Pancreatic endocrine Pdx1 (Miyazaki et al., 2004) 
mESC, 
hPSC 
Endoderm 
Plasmid transfection 
(TetO) 
β-islet cells Pdx1 (Bernardo et al., 2009) 
mESC PSC Tet-On (Kyba) Trophectoderm Ras-MAPK (C.-W. Lu et al., 2008) 
mESC EB Tet-On (Kyba) Germ cell Lin28 (West et al., 2009) 
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Methods of Forward Programming 
As with most fields, science and technology have pushed advances 
reciprocally. Initial methods used in forward programming strategies were often 
limited to constitutive constructs, which did not permit stage-specific induction and 
complicated analysis with transgene expression. Tet-On or Off systems were more 
difficult to generate because they required integration of both a transgene and an 
rtTA or tTA gene (Gossen and Bujard, 1992). These technologies, however, often 
produced inconsistent and heterogenous transgene expression making well-
controlled and defined experiments difficult to accomplish. 
  A major advance was the development of an mESC line engineered with a 
transgene targeting site (Kyba et al., 2002). In this line, rtTA was inserted into the 
constitutively active ROSA26 locus (Zambrowicz et al., 1997) and the targeting site 
at the HPRT locus. Upon transgene integration, NEO, a gene conferring antibiotic 
resistance, is functionally restored, allowing efficient selection of cells with 
successful transgene integration. The availability of this cell line and the relative 
ease it conferred for generating custom inducible cells lines greatly expanded the 
field of forward programming. Additionally, more recent advances on this construct 
have further improved the efficiency and ease of transgene-specific line generation 
(Iacovino et al., 2011a; 2014; Ting et al., 2005). An equivalent system generating for 
human PSCs has been lacking until recently (Pawlowski et al., 2017; Zhu et al., 2016)  
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which has caused a lag in some areas of human studies relative to murine forward 
programming.  
Further advances in non-integrative techniques (Bernal, 2013; Schlaeger et 
al., 2015) have been able to manipulation transcriptional identity without genome 
modification such as plasmids (Okita et al., 2008); RNA delivery (Bernal, 2013) 
including both mRNA (Warren et al., 2010) and microRNA (Anokye-Danso et al., 
2011; Jayawardena et al., 2012; J. Xu et al., 2015); small molecules (Banaszynski et 
al., 2006; Huangfu et al., 2008); as well as non-integrating viral delivery such as 
adenoviruses (Stadtfeld et al., 2008), and Sendai viruses (Fusaki et al., 2009). 
 
Illustration 1.5. A schematic of the balance between efficiency versus safety of reprogrammed 
cells for future clinical applications.  
From: RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical 
applications (Bernal, 2013). 
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Ultimately, when seeking to generate cell lineages with clinical applications, 
non-integrative methods are ideal to meet rigorous safety standards in therapeutic 
medicine. Future technologies will ideally optimize both efficiency and safety for 
translational purposes (Illustration 1.5).  
 
 
Thyroid Development & Function 
Endoderm development and patterning 
The thyroid, as well as the lung and other endodermal organs, are specified 
from foregut endoderm through multiple stages of precise patterning. During mouse 
development (E6.5), gastrulation of the epiblast initiates a large-scale cell migration 
and patterning event that ultimately gives rise to the three germ layers: ectoderm, 
mesoderm, and endoderm (Tam et al., 2006) (Illustration 1.6, upper panel). During 
gastrulation, the migration of cells is initiated through formation of the primitive 
streak that exposes populations to gradients of signaling factors (Nodal and Wnt). 
This leads to a precise patterning of germ layers and distinguishes the mesoderm 
from the endoderm along an anterior/posterior (A/P) axis (Gadue et al., 2005; Zorn 
and Wells, 2009). The anterior primitive streak (BRY+, FOXA2+) gives rise to the 
definitive endoderm (DE) (FOXA2+ and SOX17+) (Ang et al., 1993), then undergoes 
further patterning (E8.5-E9) along its own A/P axis to develop into hindgut, midgut, 
and foregut (FOXA2+, SOX2+) endoderm (Cardoso and Lü, 2006; Wells and Melton, 
1999) (Illustration 1.6, lower panel). Within these regions, localized reciprocal 
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signaling between the endoderm and adjacent mesoderm serve to specify distinct 
specific populations of organ progenitor fate. Upon further signaling, proliferation, 
and differentiation, these regions bud off from the endoderm gut tube and later 
form the endoderm component, generally the epithelial layer, of their respective 
organs.  
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Illustration 1.6. Early mouse development and organ specification.  
Upper Panel: Blastocyst progression through late primitive streak stage. From: Germ layer induction 
from embryonic stem cells (Gadue et al., 2005). 
Lower Panel: Germ layer patterning to organ specification. From: Vertebrate endoderm development 
and organ formation (Zorn and Wells, 2009). 
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Thyroid Specification & Development 
 The critical signaling pathways involved in thyroid specification from the 
AFE are highly conserved across species (Kurmann et al., 2015) and both mouse and 
Xenopus (Morvan-Dubois et al., 2008) have served as useful models for human 
thyroid development.  
The thyroid gland is composed of two cell types from two distinct origins, 
thyrocytes from the main thyroid anlage and the less abundant C cells from the 
ultimobranchial bodies. These two structures are independently specified and must 
undergo migration before they connect and ultimately merge to form the final 
complete gland.  
The epithelial thyrocytes originate from the AFE (Figure 1.2A), compose the 
majority of the thyroid gland, and are responsible for synthesizing and secreting the 
thyroid hormones. In the mouse, thyrocyte progenitors are initially specified (E8.5) 
from a ventral region of the AFE gut tube located anteriorly to the prospective lung 
domain that specifies later (E9). They later detach as they proliferate and begin to 
migrate caudally, although they remain transiently connected by the thyroglossal 
duct. Signals from the mesenchyme, including BMP4 and FGF2, are critical in thyroid 
specification (Kurmann et al., 2015). A few studies have also examined 
transcriptomic profiling of the AFE pre-organ specification and at early specification 
stages to resolve signaling pathways and gene expression changes involved at this 
critical points (Fagman et al., 2011; Millien et al., 2008).  
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The other minority cell type, the parafollicular cells or C cells, are 
neuroendocrine cells whose primary function is to secrete calcitonin, important in 
the regulation of blood calcium levels (Pearse, 1966). The C cells come from the 
ultimobranchial bodies, also known as the lateral anlagen, which originate in the 
fourth pharyngeal pouch. The germ layer of origin of the C cells is debated. Early 
studies linked them to neural crest cells which migrate into the ultimobranchial 
bodies (Le Douarin and Le Lièvre, 1970; Polak et al., 1974) based on studies 
performed in avian models, and subsequent studies have purportedly established 
they originated from the AFE (E. Johansson et al., 2015; Kameda et al., 2007).  
Both the thyroid and the C cells undergo migration from their point of 
specification to the trachea, their final place of organ development (Figure 1.2B,C). 
There, the ultimobranchial bodies connect and fuse with the thyroid anlagen (mouse 
E13.5) and the C cells are incorporated into the thyroid, where they are ultimately 
distributed among the follicles (Hoyes and Kershaw, 1985; Kusakabe et al., 2006).  
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Figure 1.2. Specification and early developmental localization of the thyroid.  
(A) Endodermal origins of the thyroid, black arrow marks the region of ventral foregut where the 
thyroid is specified. From: Germ layer induction from embryonic stem cells (Zorn and Wells, 2009). 
(B) Phase / fluorescent overlay of the Nkx2-1GFP reporter mouse at E9.5. Regions of specified Nkx2-1+ 
organ domains are labeled.  
(C) NKX2-1+ endodermal derivatives at 13.5, together and separated. 
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Thyroid Transcription Factors in Development 
At the time of initial specification, the thyroid anlage is marked by an 
emerging network of core transcription factors, beginning expression in the mouse 
at E8.5 (Illustration 1.7). Four transcription factors with critical functions have been 
identified: Nkx2-1, Pax8, Foxe1, and Hhex. These genes are highly cross-regulated 
and form a transcriptional network that stabilizes cellular identity and leads to 
growth and maturation of the thyrocytes (Illustration 1.8). They have also been 
shown to directly activate target genes involved in hormone synthesis (Tshr, Tg, 
Tpo, Nis, Slc5a5). 
 
Illustration 1.7. Developmental timing of genes expressed in the thyroid.  
Basic timeline showing the timeline of gene expression in the developing thyroid. Core transcription 
factors turn on at specification and persist through development, and functional genes turn on at 
later stages of maturation. From: Thyroid transcription factors in development, differentiation and 
disease (Fernández et al., 2015). 
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Nkx2-1, formerly known as Ttf1 or Titf1, is a homeobox transcription factor 
expressed in thyrocytes beginning at specification (mouse E8.5) and persisting 
through adulthood. Its expression is shared with two other organ domains, the lung 
epithelium and the forebrain (Q. Xu et al., 2008) (Figure 1.2A-C). Similar to the 
thyroid, Nkx2-1 is also expressed in the lung at the time of specification, which also 
arises from the AFE, although at a slightly later stage (E9). Studies performed in the 
Nkx2-1 null mouse have demonstrated a critical role for Nkx2-1 in the early 
development, but not specification, for both organs (Kimura et al., 1996; 1999; 
Minoo et al., 1999). In the Nkx2-1-null mouse, the lung is specified but fails to 
undergo branching morphogenesis, resulting in a highly underdeveloped 
hypoplastic structure lacking the complex arrangement and diversity of cell types 
that normally develop from the lung progenitor population. In the same mouse, the 
thyroid primordial population is specified, but shortly after it undergoes apoptosis 
and appears absent at later time points. Later in development and in the mature 
thyroid, Nkx2-1 is also known to bind to targets involved in hormone synthesis, 
including the thyroglobulin promoter (Civitareale et al., 1989), indicating a dual role 
in both early development and mature function, similar to the lung, where it also 
regulates surfactant protein synthesis.  
Foxe1, a forkhead box transcription factor formerly known as Ttf2, is also 
expressed from the specification stage through adulthood, however, neither the 
specification nor survival of the thyroid primordium is dependent on its expression. 
Studies from the Foxe1 null mouse (de Felice et al., 1998) demonstrate impaired 
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migration at early stages, resulting in either an absent or sublingual ectopic thyroid 
gland. Interestingly, the ectopic thyroid, while underdeveloped, is able to express 
thyroglobulin, indicating maturation is accomplished despite abnormal positioning.  
Pax8, a paired box transcription factor, is also expressed through thyroid 
development and adulthood, as well in other organs including the kidney and 
regions of the brain. However, despite the involvement of Pax8 and Nkx2-1 in 
multiple other tissues, their shared expressed is unique to the thyroid follicular 
cells, and Pax8 expression has not been detected in the C cell population at any 
stage. Pax8 has also been shown to activate thyroid transcription targets through 
physical cooperative interaction with Nkx2-1 (Di Palma et al., 2003; Pasca di 
Magliano et al., 2000). Studies from the Pax8-null mouse show an important role for 
Pax8 in early development (Mansouri et al., 1998). While the thyroid in the Pax8 
null mouse is present and undergoes full migration, development is severely 
impaired with follicles and thyrocytes largely absent, with C cells being the 
predominant cell type remaining.  
 Hhex is a homeobox transcription factor with a similar transcriptional 
patterning in the thyroid as the previously mentioned genes. It also has critical roles 
in endoderm patterning, hematopoiesis, and hepatocyte development. The Hhex 
null mouse resulted in either an absent or hypoplastic structure, indicating Hhex has 
a critical role in early thyroid development (Martinez Barbera et al., 2000). 
 Taken together, this network of transcription factors has critical roles in 
early stages of thyroid development (survival, proliferation, migration, and 
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morphogenesis). Although additional critical genes may yet be discovered, 
knowledge of this transcriptional network gives a strong starting point for studies 
regarding thyroid development, as well as dysregulation and disease. 
 
 
Illustration 1.8. Gene regulation in the thyroid by core transcription factors.  
Network of gene regulation showing known interactions of the core transcription factors (Nkx2-1, 
Pax8, Foxe1, Hhex) controlling function targets (Tg, Tpo, Tshr, etc). From: Thyroid transcription 
factors in development, differentiation and disease (Fernández et al., 2015). 
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Thyroid Structure & Function 
 As with most organs and tissues, the thyroid structure is intimately 
connected with its function. On a large scale, the thyroid gland, the largest of the 
endocrine organs, is a bi-lobed structure connected by an isthmus located at the 
trachea. The majority of its cellular composition is the thyroid epithelial follicle cells, 
while C cells compose only about 1% of the epithelium by mass (Biddinger and Ray, 
1993). These thyrocytes form large spheroidal structures, the follicles, which are 
used for storage and processing of the hormone product of the gland. These 
epithelial follicular thyrocytes are highly polarized and express an array of genes 
involved in the hormone synthesis function (Illustration 1.8).  
 Axis of regulation: An axis of multiple organs coordinates for precise 
regulation of thyroid hormone (Illustration 1.9). The hypothalamus releases TRH 
(TSH releasing hormone) that stimulates the thyrotrophs of the pituitary to release 
TSH into the bloodstream. TSH binds to its receptor, TSHR (a G-protein-coupled 
seven transmembrane receptor), to stimulate the manufacturing and secretion of 
thyroid hormone. The activity of thyroid hormone, in turn, is also regulated by other 
tissues, creating a fine-tuned and dynamic system of hormone control. 
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Illustration 1.9. Axes of thyroid hormone regulation 
From: Changes in pituitary function with ageing and implications for patient care (Veldhuis, 
2013).  
 
Synthesis and secretion of thyroid hormone: Thyroid hormone synthesis and 
secretion are accomplished by multiple coordinated processes (Illustration 1.10). 
The follicle cells uptake and accumulate iodide through the action of the sodium 
iodide symporter (NIS), expressed basolaterally. Iodide is transported across the 
cell and effluxed into the follicle colloid through the apical transporter Pendrin 
(Yoshida et al., 2002). Once in the lumen, iodide is oxidized by TPO, which requires 
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the presence of hydrogen peroxide. H2O2 is synthesized at the apical membrane by 
Duox, in a reaction requiring calcium and NADPH (Y. Song et al., 2007). TPO further 
acts to catalyze the iodination (or organification) of thyroglobulin (TG), a large 
glycoprotein also stored in the lumen that is precursor to the thyroid hormones. 
Monoiodotyrosines (MIT) and diiodotyrosines (DIT) are created from this reaction, 
and these proteins couple in the form of one MIT and one DIT to create 
triiodothryronine (T3) or two DIT to create thyroxine (T4), a reaction also catalyzed 
by TPO (Ruf and Carayon, 2006). At this stage, T3 and T4 remain bound to 
thyroglobulin, and are stored in the lumen. TSH signaling through TSHR, expressed 
on the basolateral membrane of the thyrocytes, acts through the cAMP pathway to 
prompt hormone secretion. This results in re-uptake through the apical membrane 
into the thyrocytes, where T3 and T4 are released from thyroglobulin. The 
thyroglobulin is digested, iodide unbound to the hormones is recycled, and T3 and 
T4 are exported out the basolateral membrane and released into the blood stream.  
Thyroid hormone activity: Once secreted into the blood stream, the thyroid 
hormones undergo further processing in other tissues and act on a variety of other 
tissues. T4 is the predominant form in the blood, and is more stable. Conversely, T3 
is the more active hormone, with about four times higher potency that T4, however 
other tissues can convert T4 to T3 by deiodinases, creating a secondary layer of 
thyroid hormone activity regulation. The thyroid hormones travel through the 
bloodstream and bind to nuclear hormone receptors in every tissue to enact 
regulation of gene expression involved in homeostatic systems such as metabolism, 
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the nervous system, digestion, heart rate, mood, and thermoregulation, thus have 
large-scale systematic effects on the body.  
 
 
Illustration 1.10. Schematic of thyroid hormone synthesis. 
From: Medical gallery of Mikael Häggström (Häggström, 2014) 
 
 
Thyroid Disorders 
 According to the American Thyroid Association, it is estimated that more 
than 12% of the US population will develop some form of thyroid disorder in their 
lifetime. This number is higher in women, increasing to an incidence of 1 out of 8. 
Additionally, they estimate that up to 60% of people with thyroid disorders are not 
aware of the disorder. The variety of thyroid disorders generally result in 
misproduction of thyroid hormone, leading to either hypo- or hyperthyroidism. 
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These include thyroid cancer, goiters, nodules, thyroiditis, Grave’s disease, and 
Hashimoto’s disease.  
Treatments for hyperthyroidism include beta-blockers to treat downstream 
symptoms, or anti-thyroid drugs (methimazole and propylthiouracil) to block 
production of thyroid hormones. Radioactive iodine treatment can also be used to 
partially kill and thereby reduce the number of active thyrocytes, targeted by their 
unique capability to uptake iodide. Thyroidectomies, partial or full, can also be 
performed under certain circumstances and in the case of some cancers. However, 
of these treatments, thyroidectomies as well as radioactive iodine treatments, often 
result in hypothyroidism.  
In the case of hypothyroidism, the more common of the two disorders, the 
standard treatment is supplementation with T4 hormone (L-thyroxine). Congenital 
hypothyroidism is screened for at birth, and if left untreated can result in mental 
impairment or stunted physical growth. This can be caused by mutations in Nkx2-1, 
Pax8, or Foxe1 (Castanet et al., 2002; Trueba et al., 2005). 
 
 
Clinical Significance 
Despite the overall effectiveness of hormone supplementation, individuals 
may respond with various sensitivities, so it frequently requires patient-specific 
modulation and can be difficult, often taking months, to optimize (Di Donna et al., 
2014; Ojomo et al., 2013). Additionally, clinical data indicates the daily T4 
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supplement does not precisely mimic the normal dynamic physiological function, 
often continuing to leave patients feeling unwell (Hollenberg et al., 2017).  
Based on the above, there remains much room for improvement in the 
treatment of thyroid disorders. Regenerative medicine may ultimately be able to 
provide thyroid material for transplant and present this as an alternative to the 
current treatment therapies. Gene therapy may also be a realistic option in the 
future, either by correcting genetic defects in existing thyrocyte populations, or 
targeting non-thyroid tissue for conversion into functional thyrocytes. 
Advancements in current techniques and successful clinical trials related to other 
tissues and organs may make this a realistic option in the near future. In addition to 
direct clinical options, thyroid cells and tissues created in the lab can be utilized as a 
model to study developmental mechanisms and normal functional processes. In 
vitro systems with mouse and human PSCs have the advantage of being easy to 
manipulate experimentally in culture and the ability to genetically engineer systems 
to pinpoint specific functions of critical genes. An efficient method of deriving 
thyrocytes would also present a platform for disease modeling opportunities or 
drug discovery and efficacy testing in normal, genetically engineered, or patient-
specific iPSC lines.  
 
  
  44 
Specific Aims 
The goal of this project is study the influence on Nkx2-1 expression during 
the course of PSC directed differentiation to the thyroid lineage. For this project, I 
will use a mESC line engineered with a Dox-inducible Nkx2-1 transgene allowing for 
stage specific and transient exogenous expression of Nkx2-1. This system will allow 
for the examination of thyroid-competent intermediate populations as cells are 
progressed through stages recapitulating in vivo thyroid development. Following the 
optimization of overexpression, the progeny derived using this system must be 
thoroughly characterized with regards to protein expression and functional 
hormone synthesis to establish similarity to in vivo counterparts. To apply novel 
information regarding the plasticity of in vitro endodermal populations, I propose 
the creation of a mouse model. These experiments will provide a platform for the 
high-efficiency generation of thyrocytes in vitro and improve our understanding of 
how thyroid progenitors are specified from endodermal intermediates.   
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CHAPTER II - MATERIALS AND METHODS 
Cell culture techniques and reagents 
Maintenance of mouse embryonic stem cell cultures 
Undifferentiated mESCs were maintained on a feeder layer of mitotically 
inactivated mouse embryonic fibroblasts (MEFs) in serum-containing media 
consisting of Dulbecco's Modified Eagle Medium (DMEM) (Life Technologies, 11995-
073) with 15% FBS (Thermo Fisher Scientific, NC0712155), 200 mM L-glutamine 
(Invitrogen, 25030-164) and 100 μg/ml Primocin (Thermo Fisher Scientific, 
NC9392943), supplemented with LIF-containing conditioned media (Millipore, 
ESG1106) at 1 U/ml or an equivalent concentration of conditioned LIF (Leukemia 
Inhibitory Factor) produced in our lab. Conditioned LIF was produced from stably 
transduced CHO (Chinese Hamster Ovary) cells, the supernatant was harvested, and 
the concentration of LIF was measured by ELISA.  mESCs were passaged as needed 
when cultures reached appropriate confluency using 0.05% trypsin (Invitrogen, 
25300-120) for continued expansion on MEFs or to start differentiation 
experiments. ESCs or differentiated cells were counted using the Countess II 
Automated Cell Counter (Thermo Fisher Scientific, AMQAX1000) according to the 
manufacturer’s instructions. 
Karyotype Analysis 
Cytogenetic analysis (Cell Line Genetics) was performed on twenty G-banded 
metaphase cells from the chosen mESC line. The majority (18/20) cells 
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demonstrated an apparently normal male karyotype, while two cells demonstrated 
loss of the Y chromosome (Figure S1B), a common feature of cultured mESCs. Cells 
were expanded for a minimal (≤4) number of passages before being used in 
experiments to avoid genetic instability. 
Generation of the Nkx2-1 inducible line 
The Ainv15 mESC line (Kyba et al., 2002) was a kind gift from Dr. Paul Gadue. 
As previously described (Ting et al., 2005), this line was engineered with a 
constitutively expressed rtTA from the Rosa26 locus, and a promoter with TetO 
sites upstream of a loxP site at the HPRT locus. The Nkx2-1 transgene, consisting of 
the two-exon isoform, was cloned into the plox plasmid and inserted via co-
electroporation along with the pSalk-Cre plasmid (Ting et al., 2005) into the Ainv15 
line. Colonies with restored neomycin resistance were screened by flow cytometry 
for efficient Dox-mediated Nkx2-1 induction.  
Directed differentiation reagents and protocols 
To initiate directed differentiation, ESC colonies cultured on mouse 
embryonic fibroblasts (MEFs) were trypsinized to form a single cell suspension and 
MEFs were depleted for 30 min at 37˚C in mESC media on a tissue culture dish. The 
supernatant containing the ESCs was rinsed and cells were transferred at a density 
of 500,000 cells per 10 cm petri dish into complete serum-free differentiation media 
(cSFDM) containing 75% Iscove's Modified Dulbecco's Medium (IMDM) (Life 
Technologies, 12440061) and 25% Ham’s Modified F12 medium (Thermo Fisher 
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Scientific, MT-10-080-CV) supplemented with N2 (Life Technologies, 17502-048), 
B27 with RA (Life Technologies, 17504-044), 0.05% BSA (Life Technologies, 
C15260-037), 2 mM L-glutamine (Invitrogen 25030-164), 0.05 mg/ml ascorbic acid 
(Sigma A4544-25G), 4.5x10-4M monothioglycerol (MTG) (Sigma M6145) and 100 
μg/ml Primocin (Fisher NC9392943). Cells were grown in this media for 48 hrs, 
where they formed embryoid bodies (EBs). At day 2, EBs were monodispersed by 
trypsinization and cells were re-suspended in cSFDM containing 50 ng/ml Activin A 
(R&D systems 338-AC) to re-form EBs and induce definitive endoderm. After 72 hrs 
of Activin A exposure, endoderm induction was confirmed by expression of Foxa2-
hCD4 by flow cytometry (Gadue et al., 2006; Gouon-Evans et al., 2006). EBs were 
rinsed with base media (DMEM or IMDM) and transferred to anteriorization media 
containing cSFDM supplemented with 100 ng/ml Noggin (Fisher Scientific, 1967-
NG-025) and 10 μM SB431542 (Fisher, 16-141-0) for BMP and TGFβ inhibition. 
After 24 hr exposure to these factors, EBs were trypsinized for monodispersion and 
plated at a density of 200,000 cells per 9.5 cm2 onto gelatin-coated cell culture 
dishes (Corning Costar, 3516 or 3513). Plating EBs or monodispersed cells at this 
time point did not significantly affect Nkx2-1 induction or thyroid specification 
(data not shown). Specification media from day 6 to day 14 consisted of cSFDM 
supplemented with 10 ng/ml hBMP4, 250 ng/ml rhFGF2 (R&D Systems, 233-FB-
01M) and 100 ng/ml Heparin Sodium Salt (Sigma Aldrich H3149-100KU) (Kurmann 
et al., 2015). Upon initial plating at day 6, ROCK inhibitor (Y27632, TOCRIS 1254) 
was added to the media at a concentration of 1 µM until day 7 to aid in survival of 
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monodispersed cells. Dox (Doxycycline Hyclate, Sigma, D9891-5G) was added to 
treated conditions as indicated at a concentration of 1 µg/ml and removed after 24 
hr by rinsing cultures twice with basal media and replacing with Dox-free 
specification media. Media was replaced as needed until day 14, when cells were 
harvested for analysis or passaged to day 22 or later for further expansion and 
maturation in cSFDM supplemented with 250 ng/ml rhFGF2, 100 ng/ml rhFGF10 
(R&D 345-FG), and 100 ng/ml Heparin Sodium Salt (FGF2+10 media). As indicated 
in the text, these day 14 cells were either passaged onto gelatin-coated tissue 
culture plates at a density of about 21,000 cells/cm2 or mixed into undiluted growth 
factor reduced Matrigel drops (Corning, 356231) at a density of 80,000 cells per 100 
µl. At day 22 or 30, cells were harvested for analysis as described in the following 
analysis subsections. 
For extended maturation to day 50, cells were grown and plated into 
Matrigel droplets at day 14 as described above and subsequently cultured as 
previously described (Kurmann et al., 2015). Media from D14-22 consisted of 
cSFDM supplemented with 250 ng/ml rhFGF2, 100 ng/ml rhFGF10, 100 ng/ml 
Heparin Sodium Salt, 1 mU/ml bTSH (Los Angeles Biomedical Research Institute 
National Hormone & Peptide Program, AFP-8755B), 25 ng/ml rhEGF (R&D Systems, 
236-EG), 50 ng/ml IGF1 (R&D Systems, 791-MG), and 10 μg/ml Insulin (Sigma, 
10516-5ml). Media from D22-D30 consisted of cSFDM supplemented with 250 
ng/ml rhFGF2, 100 ng/ml rhFGF10, 100 ng/ml Heparin Sodium Salt, 1 mU/ml bTSH, 
25 ng/ml rhEGF, 50 ng/ml rmIGF1, and 5 μg/ml ITS (Thermo Fisher Scientific, 
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41400045). Media from D30-D50 consisted of Ham’s Modified F12 medium 
supplemented with 10 mM HEPES (Sigma H0887), 0.25% BSA, 0.8 mM CaCl2 (Sigma, 
C1016), 50 nM Dexamethasone (Sigma, D4902), 100 ng/ml Heparin Sodium Salt, 1 
mU/ml bTSH, 25 ng/ml rhEGF, 50 ng/ml rmIGF1, and 5 μg/ml ITS. NaI (Sigma-
Aldrich, 383112) was added at a concentration of 10 μM from D40-D50. 
Directed differentiation to mesoderm consisted of a two day LIF depletion in 
cSFDM to allow formation of EBs, followed by two days mesoderm induction with 2 
ng/ml Activin A, 3 ng/ml hBMP4, and 0.3 ng/ml rmWnt3a (R&D Systems, 1324-
WN). For the purpose of experiments described, cultures at day 6 (endoderm) or 
day 4 (mesoderm) were plated either into thyroid specification media (FGF2+BMP4 
as described above) or mesodermal outgrowth media (cSFDM supplemented with 
20% FBS). Cultures were treated with Dox for 24 hr in parallel to untreated cultures, 
and analyzed after 8 days of outgrowth.  
 
Cell analysis techniques and reagents 
Immunostaining (immunohistochemistry and immunocytochemistry) 
2-Dimensional culture: Samples were grown from day 6 to day 14 or 22 
(passaged on day 14) on gelatin-coated tissue culture dishes and fixed in 4% 
paraformaldehyde (PFA) (Ted Pella, 18505) for 15 minutes, then rinsed twice with 
PBS and stored at 4˚C if staining was not performed the same day. Cells were 
permeabilized with 0.2% Triton X-100 detergent (Thermo Fisher Scientific, 28314) 
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in PBS for five minutes, rinsed twice, and then blocked with 1% BSA in PBS for 30 
minutes. The samples were then incubated with the primary antibody in 1% BSA at 
dilutions listed below overnight at 4˚C. Pax8 and Tg antibodies were blocked in 1% 
BSA with 0.1% Triton X. Fluorophore-conjugated secondary antibodies were added 
at the concentrations listed below and incubated for one hour at 37˚C and rinsed 
twice with PBS. To counterstain nuclei, cultures were incubated for 5 min with 1 
µg/ml DAPI (Life Technologies, D1306) or 500 nM PI (Life Technologies, P3566). 
Cultures were rinsed twice with PBS and stored in PBS at 4˚C until imaged. 
3-Dimensional culture: Cells were grown on gelatin-coated tissue culture 
dishes from day 6 to day 14, and then passaged into undiluted Matrigel where they 
were grown until day 22 or 30. Matrigel was dissolved using 2 mg/ml Dispase 
(Invitrogen 17105-041) in DMEM incubated at 37˚C for 30 min, or Cell Recovery 
Solution (Corning CB-40253) added for 1 hr at 4˚C.  
The resulting free-floating cell structures were fixed in 4% PFA for 15 minutes, and 
rinsed twice with PBS. Cells were then embedded into agarose (Sigma, A9414) 
melted at 67˚C, and cooled at 4˚C or on ice for at least one hour. The agar/cell pellets 
were then processed into paraffin similar to a tissue sample using standard paraffin 
embedding procedures (Sanderson et al., 2013).    
For staining of paraffin embedded sections, slides were deparaffinized and 
steamed for 30 min in Target Retrieval Solution (Dako, S1699). Individual sections 
on slides were segregated using a PAP pen (Abcam, ab2601) and were blocked with 
1% BSA in PBS for 30 minutes. The samples were then incubated with the primary 
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antibody in 1% BSA at dilutions listed below overnight at 4˚C. The next day, slides 
were rinsed twice in PBS and incubated with fluorophore-conjugated secondary 
antibodies for one hour at 37˚C followed by two rinses with PBS. Cells sectioned 
onto slides were mounted with either SlowFade Diamond Antifade with DAPI (Life 
Technologies, S36964) or were counterstained with DAPI or Hoechst (Life 
Technologies, H3570) at 20 μg/ml for 10 min and subsequently mounted with 
ProLong Diamond Antifade Mountant (Life Technologies, P36961), sealed the 
following day, and stored at 4˚C until imaging. 
Live Cell Surface Marker Staining 
Cultures were monodispersed with trypsin and rinsed with FACS buffer 
containing HBSS with 2% FBS. Cells were incubated with conjugated primary 
antibody for 30 min at 4˚C. Cells were rinsed twice with FACS buffer and then 
transferred to filter-top polystyrene FACS tubes to run on the BD FACSCalibur. Flow 
cytometry controls included unstained cells and cells incubated with an isotype. 
Live Cell Sorting 
Cells were prepared as described in Surface Marker Staining. 10 µM Calcein 
Blue, AM (Life Technologies, C1429) was added to stain cells for inclusive live 
gating. Sorting was performed in the Boston University Flow Cytometry Core 
Facility using the FACSARIA II SORP high speed cell sorter. Cells sorted at day 6 
were replated onto gelatin-coated plates with 24 hours exposure to ROCK inhibitor 
(1 μM). 
  52 
 
Fixed Cell Sorting and RNA Isolation 
Fixed cells were stained and sorted as described above, with the addition of 
RNAse inhibitor (Invitrogen, 10777-019) in staining buffer and sorting buffer. The 
RecoverAll™ Total Nucleic Acid Isolation Kit for FFPE (Thermo Fisher, AM1975) kit 
was used for RNA isolation and cell samples were processed according to the 
manufacturer’s instructions.  
 
 
 
Table 2.1. Antibody information 
Protein Target Company  Catalog Number Host Species Clonality
Flow Cyt. 
Dilution:
ICC/IHC 
Dilution:
NKX2-1 Dako M3575 Mouse monoclonal 1:200
NKX2-1 Abcam
ab76013 
(Isotype: ab172730) Rabbit monoclonal 1:50 1:200
PAX8 Abcam
ab122944
(Isotype: ab172730) Rabbit monoclonal 1:200
PAX8 Biocare
ACI438C 
(Isotype: NC490) Mouse monoclonal 1:50 1:200
TG Abcam ab80783 Mouse monoclonal 1:50 1:200
ECAD Abcam ab76319 Rabbit monoclonal 1:100
ALB Dako A0001 Rabbit polyclonal 1:1000
TUJ1 Sigma T2200 Rabbit polyclonal 1:1000
SSEA1 Millipore 90230 Mouse monoclonal 1:50
NANOG Abcam Ab80892 Rabbit polyclonal 1:50
T4 Thermo Scientific MA5-14716 Mouse monoclonal 1:100
NIS Imanis Life Sciences REA008 Rabbit polyclonal 1:2000
FOXA2 Abcam Ab108422 Rabbit monoclonal 1:300
SOX17 R&D Systems AF1924 Goat polyclonal 1:50
SOX2 BD Pharmingen 561469 Mouse monoclonal 1:100
hCD4 Life Technologies
MHCD0404
(Isotype: MG2A04) Mouse (RPE) monoclonal 1:10
SIRPA BD Biosciences
560107
(Isotype: 553925) Rat (PE) monoclonal 1:50
EPHB2 BD Biosciences 564699 Mouse (APC) monoclonal 1:50
Alexa Fluor 488 Invitrogen A10667 goat anti mouse 1:100 1:300
DyLight 550 Abcam ab96884 goat anti-rabbit 1:100 1:300
Alexa Fluor 647 Invitrogen A21245 goat anti-rabbit 1:100
1
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Image acquisition and analysis 
Fluorescent micrographs were acquired on the Cyntellect Celigo, Nikon 
Eclipse Ti inverted microscope (Boston University Cellular Imaging Core), or the 
Nikon Eclipse Ni upright microscope using the NIS-Elements software. Acquired 
ND2 files were processed with Fiji (Schindelin et al., 2012) (Schneider et al., 2012) 
to optimize clarity and create merged micrographs. Large-scale composite 
micrographs were acquired using the Nexcelom Celigo Cyntellect Imaging 
Cytometer microwell plate imager. 
Phase contrast micrographs and phase contrast / fluorescent micrographs 
were acquired using a Nikon Eclipse TS100 (Diagnostic Instruments Inc., Model 
#18.2 Color Mosaic) microscope with a Lumen200 Fluorescent Illumination (Prior 
Scientific) and the SPOT Insight Firewire 2 camera (Diagnostic Instruments Inc., 
Model 18.2) and the SPOT Software Version 4.6.1.38. 
Analysis of gene expression using RT-qPCR 
To harvest cells, cultures on tissue culture dishes were rinsed and 
trypsinized with 0.05% trypsin until dissociated. FBS (Fisher, SH3007003E) was 
added to quench enzymatic activity, and cells were rinsed with basal media (DMEM) 
and centrifuged to pellet. Cell pellets were stored at -80˚C until ready for processing.  
RNA was extracted using QIAshredder columns (QIAGEN, 79656) and the 
RNeasy Plus Mini Kit (QIAGEN, 74136) according to the QIAGEN manual 
instructions. Purified RNA was eluted in 30 µl nuclease-free water, quantified on the 
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Nanodrop (ND1000), and diluted as needed. cDNA was prepared using Taqman 
Reverse Transcription Reagents (Applied Biosystems, N808-0234). cDNA samples 
were prepared with TaqMan Fast Universal Master Mix (Life Technologies, 
4367846) and diluted to 6.25 ng per 25 µl reaction for real-time analysis on the 
StepOnePlus Real Time PCR System (Applied Biosystems). Relative expression 
analysis calculations were performed according to the ∆∆CT method (Livak and 
Schmittgen, 2001) utilizing 18S rRNA as the internal reference gene and 
undifferentiated ESCs collected prior to each differentiation as the reference sample. 
If expression was undetected based on the set threshold, the value was set to the 
maximum number of cycles (40) to allow fold change calculations. Data was 
graphed for visualization as shown in the figures using the GraphPad Prism 6 
software.  
Custom probes specific for endogenous and exogenous Nkx2-1 were 
designed using the Custom Taqman Assay Design Tool. Sequences were entered that 
spanned the transgene to the 3’ UTR to create the endogenous specific probe, and 
the transgene to the polyA tail of the transgene to create the exogenous specific 
probe.  
Initial validation for the RNA-Sequencing was performed using Custom 
TaqMan Array Plates, 96 well format (Thermo Fisher Scientific, 4413255, “Early” 
cluster Design ID: PPFGSW4, “Late” cluster Design IDs: PP4FSDO, PP5OQJW). 
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Table 2.2. RT-qPCR Taqman Probes 
 
Flow cytometry for population quantification and cell sorting (intracellular flow 
cytometry and live cell surface marker staining) 
Samples were monodispersed by trypsinization and fixed in 1.6% PFA in PBS 
for 30 min at 37˚C. Samples were stored for up to two weeks in PBS with 0.5% BSA 
and 0.02% Sodium Azide (NaN3) at 4˚C before staining. To stain, samples were 
rinsed twice in 1X Saponin buffer (Permeability Wash Buffer 10x, Biolegend 
421002). Primary antibodies were added in 1X Saponin buffer at the dilutions 
stated below and incubated for one hour at room temperature. Samples were rinsed 
Expression Target Company  Catalog Number
18S rRNA Thermo Fisher 4319413e 
Endogenous Nkx2-1 Thermo Fisher 4441117 Assay ID: AJLJIJO
Exogenous Nkx2-1 Thermo Fisher 4331348 Assay ID: AIVI6DF
Pax8 Thermo Fisher Mm00440623_m1
Tg Thermo Fisher Mm00447525_m1
Foxe1 Thermo Fisher Mm00433948_m1
Hhex (Hex1) Thermo Fisher Mm00433954_m1
Slc5a5 (Nis) Thermo Fisher Mm00475074_m1
Tpo Thermo Fisher Mm00456355_m1
Tshr Thermo Fisher Mm00442027_m1
Iyd Thermo Fisher Mm00503564_m1
Dio1 Thermo Fisher Mm00839358_m1
Sftpa (Spa) Thermo Fisher Mm00499170_m1
Sftpb (Spb) Thermo Fisher Mm00455681_m1
Sftpc (Spc) Thermo Fisher Mm00488144_m1
Scgb3a2 Thermo Fisher Mm00504412_m1
Trp63 (P63) Thermo Fisher Mm00495788_m1
Scgb1a1 (Cc10) Thermo Fisher Mm00442046_m1
Abca3 Thermo Fisher Mm00550501_m1
Col25a1 Thermo Fisher Mm00472589_m1
Gabre Thermo Fisher Mm00489935_m1
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twice with 1X Saponin buffer and then incubated with the secondary antibodies in 
1X Saponin for 30 min at room temp. They were then rinsed twice with 1X Saponin 
and transferred to PBS with 2% FBS into filter-top FACS tubes (Falcon, 352235). 
Flow cytometry data was acquired from the BD FACSCalibur using the BD CellQuest 
software. Exported sample data was gated and analyzed as shown in the figures and 
text using the FlowJo v10 software. Flow cytometry controls included unstained 
cells, cells incubated with the secondary antibody only (no primary), isotype 
controls, and negative controls (undifferentiated cells or cell populations known not 
to express the protein of interest).  
Statistical Analysis 
Error bars in graphs represent SD or SEM, as indicated in the figure legends. 
Biological sample replicates (N) are also indicated in the legends. Statistically 
significant differences between conditions (∆Ct values used for RT-qPCR 
calculations) were determined using two-tailed unpaired Student’s t-tests, or as 
specified in figure legends. Significance is represented as: p < 0.05 (*), p < 0.01 (**), 
p < 0.001 (***), p < 0.0001 (****). 
Lung mesenchyme recombinants 
Experimental cells, Day 14 Dox (D6-D7), were cultured with lung 
mesenchyme extracted from E12.5 embryos as previously described (Shannon et al., 
1998). In brief, the recombinants were co-cultured for seven day in BGJb media 
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supplemented with 10% FBS, and 5 μg/ml SHH, with 50 nM Dexamethasone added 
for the last two days, before subsequent fixation and analysis.  
Measurement of T4 hormone production by ELISA 
T4 levels in mature organoids were measured as previously described 
(Kurmann et al., 2015). Organoids were removed from the Matrigel using Dispase 
and were lysed with 330 μl per sample of cold Barbital buffer (Sigma, B5934) using 
the QIAGEN TissueLyser system. Lysate from the organoids was sonicated and 
centrifuged for 20 min at 13,000 rpm. The supernatant was divided into three 
groups for genomic DNA (gDNA) extraction, and enzyme degraded and non-
degraded samples. 
For enzymatic degradation to break down T4 from TG-T4, 150 μl of protease 
solution (Kurmann et al., 2015) and 15 μl of Toluene (Sigma, 244511) were added to 
100 μl of lysate and incubated for 48 hours at 37°C with shaking followed by 5 min 
at 98°C for enzyme inactivation. T4 concentration was measured using AccuDiag T4 
ELISA kit (Diagnostic automation/Cortez Diagnostics, Inc., 3149-18). 25 μl of 
degraded or non-degraded organoid lysates were used for measurement and 
normalized to gDNA concentration. 
Genomic DNA was extracted using Archive Pure DNA tissue kit (5Prime, 
2300860). Briefly, 300 μl of Cell Lysis Solution was added to 100 μl of organoid 
lysate followed by treatment with RNase A Solution. After incubation for 5 min at 
37°C, 100 μl of Protein Precipitation Solution was added to the lysate. After 
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centrifugation, the supernatant containing the gDNA was mixed with 300 μl of 
isopropanol and centrifuged for one hour at 4°C. The gDNA pellet was washed with 
70% ethanol and hydrated with 15 μl of DNA Hydration Solution. The concentration 
of gDNA was measured using the NanoDrop spectrophotometer. 
 
RNA sequencing  
Sample preparation and sequencing 
RNA samples were prepared for RNA-Sequencing as described for RT-qPCR. 
Samples were selected from biologically replicate runs (separate differentiations), 
in duplicate or triplicate sets. D1 RNA was limited to duplicate samples due to 
available space on the Flow-Cell. Sequencing libraries were prepared from total RNA 
samples using Illumina® TruSeq® RNA Sample Preparation Kit v2. Briefly, the 
mRNA was isolated using magnetic bead-based poly(A) selection, fragmented, and 
randomly primed for reverse transcription, followed by second-strand synthesis to 
create double-stranded cDNA fragments. These cDNA fragments were then end-
repaired, added with a single ‘A’ base, and ligated to Illumina® Paired-End 
sequencing adapters. The products were purified and PCR-amplified to create the 
final cDNA library. The libraries from individual samples were pooled in groups of 
four for cluster generation on the Illumina® cBot using Illumina® TruSeq® Paired-
End Cluster Kit. Each sample was sequenced four per lane on the Illumina® HiSeq 
2500 to generate more than 25 million Paired-End 100-bp reads. The RNA-Seq 
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reads were aligned to mouse genome mm9 by Tophat v2.0.4 (Kim et al., 2013). Then 
the reads were summed to the gene level by HTSeq package (Anders et al., 2015). 
This data has been deposited in NCBI's Gene Expression Omnibus and are accessible 
through GEO Series accession number  
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE92572.  
A generalized linear model implemented by edgeR package was used to 
extract the differentially expressed genes between each two-condition comparison 
(D14 vs. D0, D7 vs. D0, D14 vs. D7) with a false discovery rate (FDR) cutoff at 0.05 
(Robinson et al., 2010). Finally, a hierarchical clustering was performed on the 
combined differentially expressed gene list across all samples. Data were log-
transformed with gene expression counts, mean centered, and row scaled. To 
generate the heat map, hierarchical agglomerative clustering was performed via 
Pearson correlation similarity metric with average linkage used to determine 
pairwise distance. Java Treeview (Saldanha, 2004) was used to generate the heat 
map visualization and for extraction of the gene lists comprising the main clusters.  
Identification of Putative Cell Surface Markers and Transcriptional Regulators 
Cell surface markers (cut-off of p<0.001) were identified using DAVID 
(Huang et al., 2009) through categorization in GO term “Integral to Plasma 
Membrane” (GO:0005887) and manually curated to exclude genes encoding for 
proteins not transmembrane or plasma membrane bound. Transcription factors 
(cut-off of p<0.001) were selected using correlation (4/5 or 5/5) with the five 
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reference lists: Animal Transcription Factor DataBase (AnimalTFDB v2.0 2014-06-
30) (Zhang et al., 2012), Riken Transcription Factor Database, TFdb (Kanamori et al., 
2004), TFcheckpoint (Transcription Factor Checkpoint, (Chawla et al., 2013)), and 
classification by DAVID within GO terms “Transcription Factor Activity” 
(GO:0003700) and “DNA Binding” (GO:0003677). Small-scale heat maps in the 
figures were generated using GENE-E 
(http://www.broadinstitute.org/cancer/software/GENE-E/). 
Gene Ontology Analysis 
Lists of significantly (FDR <0.05) differentially expressed genes were entered 
into the Gene Ontology Consortium online resource (Ashburner et al., 2000; 
Consortium, 2015). GO terms with a p-value of <0.05 were entered into the REVIGO 
website for consolidation (Supek et al., 2011), using PANTHER Overrepresentation 
Test (release 2015-04-30) and GO Ontology database (release 2015-08-06). The 
log10 p-values of the GO term output were used for the graphical representation of 
associated biological processes. 
GSEA analysis 
Genes from the “Early” and “Late” clusters were ranked on logFC values. 
Gene sets were selected from ‘gene set data for pathway analysis in mouse’ R 
package (Bares V and Ge X (2015). gskb: Gene Set data for pathway analysis in 
mouse. R package version 1.2.0). Specifically, we used all the provided 259 KEGG 
gene sets from the ‘Metabolic pathways’ set and all 12525 GO gene sets from the 
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‘Gene Ontology’. The command-line version of GSEA (Mootha et al., 2003; 
Subramanian et al., 2005) was used in the ‘Preranked’ mode (specifically: gsea2-
2.1.0.jar -Xmx512m xtools.gsea.GseaPreranked) and ‘classic’ scoring scheme, as 
advised for RNA-Seq data in the FAQ section of GSEA online documentation. We ran 
GSEA with the default parameters. Gene sets included in the figure were selected 
based on a cutoff of FDR < 0.2. 
 
Principal Component Analysis 
Before PCA, expression values were normalized across all samples to a mean 
of zero and a standard deviation of one. PCA of the normalized data was performed 
using the sklearn.decomposition.PCA command in the Python package scikit-learn. 
 
Gene Expression Projections 
Here we give a brief overview of the projection method plots shown in Figure 
3.29A-C, please see (Lang et al., 2014; Pusuluri et al., 2015) for complete 
mathematical details. The projection method allows one to compare experimentally 
acquired gene expression data versus a reference basis. A projection score of 1.0 
indicates a perfect match of gene expression, while 0.0 indicates no match. The 
projection method has several key advantages relative to other techniques such as 
PCA. First, it provides a biologically interpretable numeric value of the similarity 
between the data and the reference basis. Second, it removes the inherent 
correlations of the reference basis by measuring orthogonal projections onto the 
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reference basis. This means that each reference cell type has a projection of 1 with 
only itself and has a projection of 0 with all other reference cell types.  
To create the reference basis cell types, we first started with the basis used in 
(Lang et al., 2014; Pusuluri et al., 2015). We removed the following cell types: 
Common Lymphoid Progenitor (CLP), Common Myeloid Progenitor (CMP), 
Granulocyte-Monocyte Progenitor (GMP), and Megakaryocyte-Erythroid Progenitor 
(MEP). Second, we included E8.25 ectoderm, E8.25 foregut, and E14.5 Nkx2-1+ 
thyroid RNA-Seq samples from our lab. The basis thus consists of 62 cell types. 
The dataset consists of a mix of Affymetrix GeneChip Mouse Gene 1.0 ST and 
RNA-Seq data and was normalized as follows. First, raw microarrays and RNA-Seq 
were separately processed following standard techniques for each data type. Next, 
only genes common to all datasets were kept, leading to N=12039 genes. In order to 
make robust comparisons across platforms the raw expression output was 
converted to a rank order. Next, we wanted to convert this rank order to the z-score 
of a log-normal distribution. We converted the rank to a percentile (for N genes, by 
dividing by N+1), and then this percentile into a normal z-score. For mathematical 
convenience, we used a biased estimator (i.e. we normalized by N and not N-1) since 
then the Euclidean norm of each microarray gene expression was N. Therefore, for 
the data analysis each sample is described by a Gaussian distribution with a 
Euclidean norm of N = 12039. 
As mentioned above, a projection score of 1.0 indicates a perfect match of 
gene expression, 0 indicates no match, and -1.0 indicates perfectly anti-correlated 
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gene expression. There are no direct equivalents of p-values to measure the 
significance of a projection. However, one can compare the expression of random 
sets of gene expression versus the reference basis. A random set of 10,000 different 
gene expression profiles (each with N=12039 genes) had a mean projection of 0 
(within machine precision) with any of the reference cell types, while the standard 
deviation of the projections was 0.0184. Therefore, a projection greater in 
magnitude of 0.092 (5 stds) is highly unlikely to be due to random expression 
patterns. This is also supported by the fact that the variation in the projections of 
each experimental replicate was minimal.  
 
 
.  
Mouse Techniques 
Tamoxifen induction for lineage labeling 
For the Nkx2-1 lineage trace cross, Nkx2-1-CreERT2 (Jackson Laboratory, 
strain 014552) sires were crossed to ROSAnT-nG (Jackson Laboratory, strain 023035) 
dams and were checked daily for plugs. The presence of a plug established E0.5. 
Tamoxifen (Sigma, T5648) was prepared the day before injection at a concentration 
of 30 mg/ml dissolved in 90% corn oil with 10% ethanol. Pregnant dams were 
weighed to calculate the correct dosage of tamoxifen by weight, and subsequently 
anesthetized with isoflurane (Henry Schein, IsoThesia) and given an intraperitoneal 
injection of the tamoxifen solution. For embryonic studies, dams at E14.5 were 
euthanized with isoflurane and confirmatory cervical dislocation, embryos removed, 
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and embryonic lungs resected. For post-natal analysis, mice were euthanized at 
three weeks after birth. Lungs were removed, inflated with 4% PFA solution, and 
processed as described below.  
 
Tissue fixation and embedding 
Embryonic and adult lungs were fixed overnight in 4% Paraformaldehyde in 
PBS pH 7.4 with rotation at 4°C. The following day, they were washed in PBS for 
three 10 min rinses on ice, followed by six  10 min rinses with 7.5% sucrose 
(Thermo Fisher S3-500) in PBS on ice, and then incubated overnight in 30% sucrose 
in PBS (pH 7.4) at 4°C with rotation. The third day, they were incubated in 30% 
sucrose in PBS (pH 7.4) for 1 hr at 4°C with rotation, rinsed in Tissue-Tek O.C.T. 
Compound (VWR, 25608-930), and frozen in cryomolds in liquid nitrogen-cooled 
isopentane (2-Methylbutane). Frozen blocks were stored at -80°C until sectioned. 
 
 
Mouse genotyping 
Mice were genotyped using DNA extracted from tail tip samples. Tail tips 
were incubated for three minutes in lysis solution (Sigma Aldrich REDExtract-N-
Amp™ Tissue PCR Kit, XNAT—1KT) and neutralized according to the manufacturer’s 
instructions. Primers stocks were diluted as recommended by IDT and PCR 
reactions were prepared with the Red Extract reaction mix from the kit. PCR 
reactions were run on standard thermal cyclers and subsequently run on gels to 
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confirm bands. Agarose (Invitrogen 16500-600) gels were prepared at 1% with 
buffer TAE (Invitrogen, 24710-303) and DNA dye (Biotium, 41003). Gels images 
were acquired on the Gel Doc XR (Bio-Rad) using the Quantity One software.  
 
  
 
Table 2.3. Mouse strain and genotyping information 
 
 
Immunostaining 
 
Frozen sections: Sections on slides were rinsed 3x 5 min in PBS at room 
temperature. They were then permeabilized with 0.2% Triton-X in PBS for 10 min 
and washed 3x 5 min in PBS. They were then blocked and stained as previously 
described for paraffin embedded sections.  
 Paraffin-embedded sections: Slides were stained as described above for 
embedded cell culture samples.  
 
Mouse Strain Primer Sequence 5' to 3'
14015 GCC TCC ACT CAA GCC AAT TA
14016 CCT GGC CCT GTC TGT ACG
oIMR9377 ATG TTT AGC TGG CCC AAA TG
9655 CCA GGC GGG CCA TTT ACC GTA AG
oIMR8545 AAA GTC GCT CTG AGT TGT TAT
oIMR8546 GGA GCG GGA GAA ATG GAT ATG
GAC TAC AAA GAC CAT GAC GGT GAT
TCA CGT TGC CCA GGT TGC CGT TGC AGT A
oIMR9017 GAC CTC AAG GCC TAC GAA CA
oIMR9018 GAC TTT TCT GCA ACA ACA GCA
oIMR9019 TCA TAT GTG GCC TGG AGA AAC
Nkx2-1CreERT2    
(JAX 014552)
ROSAnT-nG      
(JAX 023035)
TetO-Nkx2-1 
(Jeffrey Whitsett)
Foxa2rtTA           
(JAX 008335)
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Lung digestion and flow cytometry 
Lung tissue was minced with a razor blade and incubated for 1 hr at 37°C 
with periodic gentle trituration in an enzymatic digestion solution of 2.4 U/ml 
Dispase II (Roche, 295825), 0.1% Collagenase A (Roche, 103578), and 2.5 mM CaCl2 
in PBS. After 1 hour, 1 mL of HBSS+ (HBSS+2% FBS) was added, sample was 
carefully triturated, then spun down at 4°C for 1-2 minutes at 300 g, and rinsed 
again in HBSS+. The pellets were resuspended in Red Blood Cell Lysis Buffer (Sigma, 
R7757), mixed gently for 1 minute, and diluted in HBSS+. Samples again were spun 
down, pellets were resuspended in HBSS+, and filtered through 30 µm FACS 
strainers (Miltenyi Biotech, Cat#130-041-407) and kept on ice prior to sorting or 
flow cytometry analysis (see above sections for details). 
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CHAPTER III - THYROID PROGENITORS ARE ROBUSTLY DERIVED FROM 
EMBRYONIC STEM CELLS THROUGH TRANSIENT, DEVELOPMENTAL STAGE-
SPECIFIC OVEREXPRESSION OF NKX2-1 
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Illustration 3.1. Graphical summarization of Chapter III results.  
From: Thyroid Progenitors Are Robustly Derived from Embryonic Stem Cells through Transient, 
Developmental Stage-Specific Overexpression of Nkx2-1 (Dame et al., 2017). 
 
 
Introduction 
Since tissue progenitors, giving rise to all mature cell types within a given 
tissue, are essential intermediates in embryonic development, their in vitro 
derivation has important implications for the fields of pluripotent stem cell (PSC) 
biology and regenerative medicine. Significant advances in anterior foregut 
endoderm (AFE) progenitor biology in recent years (Ikonomou and Kotton, 2015) 
have led to derivation of AFE lung and thyroid progenitors (TPs) and their clinically 
relevant progeny from PSCs  
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(Green et al., 2011; S. X. L. Huang et al., 2013; Kurmann et al., 2015; Longmire 
et al., 2012; Mou et al., 2012). However, with one notable exception (S. X. L. Huang et 
al., 2013), efficiencies of progenitor derivation have been relatively low (<40%). 
Overexpression of transcription factors (TFs) is a well-established approach 
to manipulate cellular identities as it results in reconfiguration or emergence of core 
TF networks, with derivation of induced PSCs from somatic cells being the most 
prominent example (Takahashi and Yamanaka, 2006). Inducible TF expression in 
differentiating PSCs has been used to potentiate the derivation of specific lineages 
and facilitate mechanistic understanding of cell specification (Bondue et al., 2008; 
Mazzoni et al., 2013; Petros et al., 2010; Séguin et al., 2008). For example, 
Costagliola and coworkers (Antonica et al., 2013) used forced overexpression of the 
thyroid TFs NKX2-1 and PAX8 in mouse embryonic stem cells (mESCs) to produce 
thyrocyte-like cells with high efficiency (~60%) that formed in vitro follicular 
structures and rescued athyroid mice upon transplantation. However, studies that 
systematically investigate the mechanistic interplay between pulsed heterologous 
TF expression and developmental stages in directed differentiation of PSCs are 
lacking. To address this question, we used thyroid directed differentiation 
(Kurmann et al., 2015) in combination with transient NKX2-1 overexpression as our 
model system. 
Here we report that transient expression of NKX2-1 functions as an inductive 
signal during thyroid directed differentiation to convert AFE-stage cells to 
thyrocyte-like cells that self-organize to epithelial, follicle-like structures in 3D 
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Matrigel culture. This thyroid conversion effect pertains only to a narrow 
developmental window of competence contingent on several parameters, including 
dual BMP and FGF signaling and correct anterior patterning (anteriorization) of 
definitive endoderm (DE). We employ emerging computational methods (linear 
algebra projections, (Lang et al., 2014; Pusuluri et al., 2015) and genome-wide gene 
expression analysis by RNA-Seq to demonstrate the resulting cells are similar to 
mouse embryonic thyrocytes. Finally, we use mathematical parameters to suggest 
that the induction effect can be modeled by a time-dependent bistable switch.  
 
Results I – Inducible Nkx2-1 line 
Derivation of the inducible Nkx2-1 mouse embryonic stem cell line 
We hypothesized that transient, temporally-regulated Nkx2-1 overexpression 
during directed differentiation of mESCs would lead to distinct differentiation 
outcomes due to differential competence of in vitro developmental stages. To this 
end, we created an mESC line (iNkx2-1) with a Doxycycline (Dox)-inducible Nkx2-1 
transgene (Figure 3.1A-C) (Ting et al., 2005). This line was previously targeted with 
knock-in reporters for Foxa2 (Foxa2hCD4) and T (BryGFP) (Gadue et al., 2006), 
engineered to facilitate tracking of developmental progression. This line retained a 
normal karyotype and expressed the array of markers indicative of pluripotency 
(Figure 3.2A,B). 
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Characterization of iNkx2-1 line and expression kinetics in undifferentiated cells 
The iNkx2-1 line displayed rapid on/off kinetics in response to Dox (Figure 
3.3). This system allowed for efficient manipulation of NKX2-1 expression, resulting 
in robust induction of the Nkx2-1 transgene (>95% NKX2-1+ cells by flow 
cytometry) following 24-hr exposure to Dox at a concentration of 1 μg/ml 
supplemented in the media (Figure 3.3A-C). Following removal of Dox, transgene 
expression in the undifferentiated cells rapidly decreased, with no visible 
expression remaining seven days later (Figure 3.3D). Additionally, the MFI of the 
NKX2-1+ population was consistently high above 0.1 µg/ml of Dox, indicating the 
effect of the Dox regulates the percentage of NKX2-1+ cells and not the levels of 
expression per cell (Figure 3.3E). 
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Figure 3.1. Development of the iNkx2-1 line 
A. Integration schematic of the Nkx2-1 transgene into the HPRT locus. 
B. Schematic of the knock-in reporters (BrachyuryGFP and Foxa2hCD4) and rtTA engineered into the 
iNkx2-1 line.  
C. Plasmid map containing the Nkx2-1 transgene used to generate the iNkx2-1 line (Vector NTI 
graphic). 
pLox-Nkx2-1-vector designed and characterized by Letty Kwok 
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Figure 3.2. Characterization of the pluripotent iNkx2-1 line 
A.  Karyotyping results for the iNkx2-1 line. 
B.  Immunostaining for markers of pluripotency in undifferentiated iNkx2-1 mESC colonies. Scale 
bar represents 200 μm. 
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Figure 3.3. Characterization of the inducible kinetics of the iNkx2-1 line 
A. Intracellular flow cytometry for NKX2-1 in undifferentiated cells with and without 24 hr of Dox 
treatment. 
B. Immunostaining of undifferentiated iNkx2-1 cells post-24-hr Dox; nuclear counterstain with 
propidium iodide (PI). Scale bars represents 100 µm. 
C. Dose response curve showing the percentage by flow cytometry of undifferentiated mESC cells 
expressing NKX2-1 24 hr following a logarithmic gradient of Dox concentrations added to the 
media (n=2 independent experiments). Higher doses (>10 µg/ml) appeared to have a toxic effect 
on the cells (data not shown). A sigmoidal dose response, variable curve models the equation 
Y=3.190+95.79-3.1901+10Log-1.028-X(-1.309) 
D. Off kinetics of NKX2-1 expression in the iNkx2-1 line by flow cytometry following the removal of 
Dox from the media of undifferentiated cells (n=3 independent experiments) showing the 
percentage of cells steadily decreases, with virtually no remaining NKX2-1+ cells after one week. 
The trend line models a plateau, followed by one phase decay according to the equation Y= IF 
(x<1, 92.45, -91.38+(183.8)e-0.1211*x-1) 
E. Flow cytometry median fluorescence intensity (MFI) of the NKX2-1+ population, following 24 hr 
of treatment with increasing doses of Dox. 
Characterization of line performed in part by Talitha Wilson and Reeti Sanghrajka  
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Results II - Stage-specific effect of Nkx2-1 overexpression 
Introduction 
To test the temporal effects of Nkx2-1 overexpression on thyroid derivation, 
we employed our iNkx2-1 cell line in combination with our thyroid differentiation 
protocol (Kurmann et al., 2015) (Figure 3.4A) which recapitulates key stages of 
thyroid development corresponding to in vivo. In short, DE is induced by Activin A 
(Kubo et al., 2004), followed by further patterning to AFE (anteriorization) (Green et 
al., 2011) (Longmire et al., 2012) using brief dual BMP/TGF-β inhibition through 
Noggin/SB431542 (NS) treatment. The AFE is subsequently specification to NKX2-
1+ TPs with combinatorial BMP4 and FGF2 signaling. While this protocol is effective 
and reproducible, the yield is generally low, (up to 25% NKX2-1+ cells) furthermore 
of which a fraction (~5%) of this population co-expresses PAX8 (Kurmann et al., 
2015), indicative of thyroid. 
 
Identification of thyroid-competent developmental stage 
We first examined the effect of single 24 hr pulses of Dox-mediated transgene 
induction at biologically intermediate stages of differentiation. Parallel cultures 
received Dox at one of the following stages (D=day of differentiation): D0-D1 
(exiting pluripotency), D5-D6 (DE stage), D6-D7 (AFE stage), or D7-D8 (early 
thyroid specification stage) (Figure 3.4B,C). In response to Dox, transgene activation 
resulted in >90-95% NKX2-1+ cells within 24 hr at all time points (Figure 3.4F and 
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data not shown). Intermediate stages of development varied in their response to the 
NKX2-1 transgene overexpression and a substantial increase of resulting 
endogenous NKX2-1+ cells was highly restricted to a narrow window of induction at 
the AFE stage (Dox D6-D7) (Figure 3.4C-E). Additionally, all other stages had low 
endogenous Nkx2-1 expression immediately post-Dox (Figure 3.4D), showing a 
relatively weak response to the transgene overexpression (Oguchi and Kimura, 
1998).  
This effect of Nkx2-1 overexpression at the AFE stage consistently resulted in 
a dramatic increase in the derivation of NKX2-1+ cells (Figure 3.4G,H) indicating a 
singular competent stage where NKX2-1 acts as an inductive lineage specification 
signal. 
Imaging and flow cytometry also reveal the extent of induction by D14 post-
Dox (Figure 3.5A,B). Additionally, parallel differentiations with the parental 
untargeted line with or without Dox demonstrated comparable NKX2-1+ 
specification to the non-induced iNkx2-1 line, indicating Dox treatment alone does 
not effect Nkx2-1 and the induction effect is not attributable to any “leakiness” of the 
transgene (Figure 3.5B).  
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Figure 3.4. Stage-specific effect of Nkx2-1 overexpression on derivation of NKX2-1+ 
progenitors  
A. Directed differentiation protocol for NKX2-1+ TPs. 
B. Experimental schematic for (C) 
C. Intracellular NKX2-1 flow cytometry plots from D14 following 24-hr pulses of Dox added at 
indicated intermediate stages. Representative of three differentiations. 
D. Kinetics of endogenous Nkx2-1 expression by RT-qPCR following 24-hr staged pulses of Dox. 
Fold changes relative to undifferentiated cells. Fold changes are calculated relative to D0 
undifferentiated cells, error bars represent SD (n=3 wells from same differentiation). 
Representative of three independent experiments. 
E. Time course of exogenous and endogenous Nkx2-1 expression following Dox treatment from D6-
D7. Error bars represent SEM from three independent experiments. 
F. Representative flow cytometry plot of NKX2-1 expression directly post-24-hr Dox.  
G. Averaged flow cytometry data (n=12 independent experiments) comparing untreated (no Dox) 
and treated (Dox D6-D7) samples. Error bars represent SEM. 
H. Representative immunostaining of Dox-induced and un-induced cultures at D14. Scale bars 
represents 100 µm. 
Dox induction kinetic performed in part by Steven Cincotta 
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Figure 3.5. The extent of D14 Nkx2-1 Induction (Post-Dox D6-D7) revealed by imaging 
A. A composite, large-magnification image showing immunostaining for NKX2-1 (right panel), 
counterstained with DAPI (left panel). Magnified area (red inset) shows nuclear localization. 
B. D14 flow cytometry from parallel differentiations using the parent untargeted line and the 
targeted inducible line with and without Dox addition D6-D7.   
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Results III - Robust thyroid development following Nkx2-1 overexpression 
Thyroid marker expression at early and late time points 
Next we asked: Does stage-specific, transient Nkx2-1 overexpression 
potentiate the thyroid lineage or the derivation of non-thyroid NKX2-1+ lineages? 
Early (Pax8, Hhex, Foxe1) and more mature (Tg, Tpo, Nis, Tshr, Iyd, Dio1) thyroid 
markers showed distinct activation kinetics along the differentiation course with 
thyroid marker expression notably induced following the D6-D7 Dox induction 
(Figure 3.6A). Although some lung-related markers (Sftpa1, Sftpb, Sftpc, Scgb3a2) 
were also induced at early time points, not all expression levels were maintained at 
high levels to later time points. Both early (Nkx2-1, Pax8, Foxe1, Hhex) and more 
mature (Tg, Tpo, Nis, Tshr) genes were upregulated at D14 and D22 in the Dox D6-
D7 induced cultures at levels comparable to in vivo purified NKX2-1GFP+ E13.5 
thyrocytes (Longmire et al., 2012) and adult mouse thyroid tissue (Figure 3.7A,B). 
Immunostaining confirmed the expected nuclear presence of NKX2-1 and PAX8, as 
well as cytoplasmic TG, expressed more extensively at D22. 
Quantification and statistical analysis of derived thyroid populations 
Large-scale imaging revealed the extent and topography of the Nkx2-1+, 
Pax8+ population, showing specification throughout the well (Figure 3.8). Flow 
cytometry quantification analysis confirmed the prevalence of this double 
population and showed the increasing presence of TG to D22/30 (Figure 3.9A,B), 
indicative of growth and maturation of the TP population. 
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These results show that overexpression of NKX2-1 can be used as an 
inductive signal to efficiently and robustly specify thyrocyte-like cells from AFE 
resulting in the derivation of in vitro cells exhibiting characteristics typical of 
murine thyrocytes. 
 
 
 
 
Figure 3.6. Gene expression kinetics following Nkx2-1 overexpression 
A. Time course of thyroid and lung marker gene expression by RT-qPCR following individual 
24-hr pulses of Dox treatments at specific stages of the directed differentiation protocol. Fold 
changes are calculated relative to D0 undifferentiated cells. Representative of three 
independent experiments. 
Lung-Related Markers 
F
o
ld
 C
h
a
n
g
e
 
Thyroid Markers 
F
o
ld
 C
h
a
n
g
e
 
Day 0        1 2 5 6 7 8 9 14
0
10000
20000
30000
40000
Endogenous Nkx2-1
No Dox
Dox D0-D1
Dox D5-D6
Dox D6-D7
Dox D7-D8
Day 0        1 2 5 6 7 8 9 14
0
2000
4000
6000
Sftpa1
Day 0        1 2 5 6 7 8 9 14
0
10000
20000
30000
Sftpb
Day 0        1 2 5 6 7 8 9 14
0
50
100
150
200
Sftpc
Day 0        1 2 5 6 7 8 9 14
0
1000
2000
3000
Scgb3a2
Day 0        1 2 5 6 7 8 9 14
0
50
100
150
200
Pax8
Day 0        1 2 5 6 7 8 9 14
0
200
400
600
Foxe1
Day 0        1 2 5 6 7 8 9 14
0
10
20
30
40
Hhex
Day 0        1 2 5 6 7 8 9 14
0
1000000
2000000
3000000
Tg
Day 0        1 2 5 6 7 8 9 14
0
50000
100000
150000
200000
Iyd
Day 0        1 2 5 6 7 8 9 14
0
100
200
300
Dio1
A 
  82 
 
Figure 3.7. Nkx2-1 overexpression at AFE stage results in efficient thyroid differentiation 
A. Experimental schematic of the extended culture conditions in Figures B and C. 
B. RT-qPCR for thyroid marker expression. Fold changes calculated relative to undifferentiated 
cells, error bars represent SEM (n=5 independent experiments, n=1 controls). 
C. Immunostaining of induced cultures at D14, D22 (2D substratum). Scale bars represent 100 µm. 
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Figure 3.8. Extent of D14 Nkx2-1 colocalization with Pax8 (Post-Dox D6) revealed by imaging. 
A composite, large-magnification image showing immunostaining for NKX2-1 (top), costained with 
Pax8 (middle) and overlayed (bottom). Magnified area (blue inset) shows nuclear localization. 
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Figure 3.9. Flow cytometry quantification of cells expressing thyroid proteins 
A. Intracellular flow cytometry for populations at D14 (upper panel), separate differentiation single 
stains at D22 (lower panel). 
B. Percent positive populations of NKX2-1, PAX8, TG quantified by flow cytometry. Error bars 
represent SD (n=4 independent experiments). 
 
 
 
NKX2-1+ lung lineages are not derived following transient Nkx2-1 overexpression 
Although NKX2-1 is also critical for the development of the lung and 
forebrain (Kimura et al., 1996) (Q. Xu et al., 2008), we found minimal evidence of 
any other lineage affected by Nkx2-1 induction. Although several lung-related 
makers appeared to be upregulated directly following Nkx2-1 overexpression 
(Figure 3.6A), these markers did not persist as robustly as the thyroid markers, 
particularly when compared to relative expression from in vivo controls (Figure 
3.10A). Furthermore, many of the available markers used to identify lineages are not 
lung specific and are not involved in lineage determination (e.g. transcription 
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factors). Notably, the most specific lung lineage marker, SPC, was not significantly 
induced in either Dox treated or untreated conditions (Figure 3.10A). Using an SPC-
reporter construct, a minor number of SPC+ cells was detected, indicating that any 
lung lineage derivation was insignificant (Figure 3.10B). Additionally, non-
colocalization of NKX2-1 with SOX2 (expressed in early lung progenitors) further 
indicates the absence of lung lineages (Figure 3.10C). Because Sftpb was highly 
expressed at the RNA level (Figure 3.10A), we were interested to determine if this 
gene were also expressed at the protein level, however, the SPB protein was not 
detected (Figure 3.10D). Furthermore, by sorting fixed populations and analyzing 
gene expression, we found Sftpb expression localized to the NKX2-1+, PAX8+ 
population, indicating Sftpb is expressed in the thyroid population and is not 
representative of a separate lineage (Figure 3.11A,B). Additionally, recombinations 
with lung mesenchyme, providing strong lung lineage specification and 
differentiation signals (Shannon and Hyatt, 2004), instead resulted in continued 
robust thyroid differentiation, further demonstrated the establishment of the 
thyroid lineage and indicated these cells were refractory to lung specification 
(Figure 3.11A-C).   
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Figure 3.10. Analysis of lung-related markers 
A. Gene expression by RT-qPCR of lung markers in the Dox-treated (D6-D7) and untreated 
conditions (n=5 independent experiments). Controls are FACS purified Nkx2-1GFP+/- lung 
populations and whole lung from an adult Nkx2-1GFP reporter mouse, as well as E13.5 Nkx2-1GFP+ 
thyroid and adult thyroid,. Fold changes are calculated relative to D0 undifferentiated cells, error 
bars represent SEM (n=5 independent experiments). 
B. Cells transduced with the SPC-dsRed reporter lentivirus show minimal induction of the lung 
alveolar marker SPC by D27. Scale bars represents 100 µm. 
C. Immunostaining of D14 Dox-treated (D6-D7) conditions shows non-overlap of NKX2-1 with 
SOX2 (endodermal or lung lineage marker). Scale bars represent 100 µm. 
D. Western blot for SPB forms. Controls include GAPDH run as loading control with mouse alveolar 
type 2 (AT2) lung cells and human fetal lung (HFL). PT3 antibody (left blot) to detect mature SP-
B as well as all intermediates in human fetal lung tissue (everything but 10 kDa intermediate in 
mouse AT2), and Nflank (right blot) to detect more robustly any expression of proSP-B and 
intermediates (in human and mouse, except for lack of 10 kDa in mouse). The PT3 blot shows SP-
B homodimer at 16 kDa, 10 kDa intermediate, and 8 kDa mature SP-B visible in the human fetal 
lung (HFL) sample with the 16 kDa and 8 kDa bands visible in the AT2 sample. The Nflank blot 
shows strong bands for 42 kDa proSP-B, a 25 kDa intermediate (and possibly a cleavage product 
below it), and 10 kDa intermediate in the human fetal lung sample, with the 42 kDa ProSP-B and 
25 kDa intermediate in the mAT2 sample. Western blot run by Seunghyi Kook (Susan Guttentag), 
Vanderbilt University. 
 
 
 
 
 
 
 
Figure 3.11. Analysis of markers by population 
A. Representative schematic of differentiated cells that received Dox D6-D7 and were fixed and 
sorted at D14 or D22. 
B. Gene expression of markers from populations in (A) 
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Figure 3.12. Recombinations with lung mesenchyme.  
A. Experimental schematic. 
B. Immunostaining of D14 Dox-treated (D6-D7) conditions shows extensive expression of NKX2-1 
colocalized with PAX8.  
C. Magnified view of (B) to show nuclear expression.  Lung mesenchyme recombinations performed 
by John Shannon 
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Figure 3.13. Analysis of neural lineage markers.  
A. Gene expression by RT-qPCR of neuronal markers in the Dox-treated (D6-D7) and untreated 
conditions (n=5 independent experiments). Controls are FACS purified E9.5, E13.5 Nkx2-1GFP+ 
forebrain cells. Fold changes are calculated relative to D0 undifferentiated cells, error bars 
represent SEM (n=5 independent experiments). 
B. Immunostaining of D14 Dox-treated (D6-D7) conditions shows non-overlap of NKX2-1 with 
SOX2 (endodermal or lung lineage marker), ALB (liver marker) and TUJ1 (neural marker). Scale 
bars represent 100 µm. 
C. Large-scale imaging of D14 Dox-treated (D6-D7) conditions shows the full extent of non-NKX2-1+ 
neural derivation in a well.  
 
 
 
NKX2-1+ neuronal lineages are not derived following transient Nkx2-1 overexpression 
Likewise to the lung, we also found no evidence of Nkx2-1-induced neuronal 
specification using this protocol. Although the nature of this differentiation results 
in a heterogeneous final population, neuronal markers were not upregulated in the 
Dox-induced protocol (Figure 3.13A) nor were the neurons present found to be of 
the NKX2-1+ lineage (Figure 3.13B). Whole-well imaging also demonstrated the 
segregation of neuronal and Nkx2-1+ lineages (Figure 3.13C).  
 
Alternative endodermal differentiation not affected 
We also investigated the possibility that Nkx2-1 overexpression affects other 
endodermal lineages. However, we found that liver induction was not increased in 
the induced protocol (Figure 3.14A), and there was no ectopic expression of NKX2-1 
in cells expressing liver makers (Figure 3.14B,C), indicating NKX2-1 induction does 
not affect or persist in this endodermal lineage. 
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Figure 3.14. Analysis of alternative endoderm lineage (liver) markers.  
A. Gene expression by RT-qPCR of liver markers in the Dox-treated (D6-D7) and untreated 
conditions (n=5 independent experiments). Fold changes are calculated relative to D0 
undifferentiated cells, error bars represent SEM (n=5 independent experiments). 
B. Immunostaining of D14 Dox-treated (D6-D7) conditions shows non-overlap of NKX2-1 with ALB 
(liver marker). Scale bars represent 100 µm. 
C. Large-scale imaging of D14 Dox-treated (D6-D7) conditions shows the full extent of NKX2-1+ and 
liver cell segregration in a well.  
 
 
Results IV – Thyroid Progenitor Maturation and Functionality 
Matrigel 3D culture enhances maturation 
To enhance the maturation of our thyrocyte-like cells, we cultured cells in a 
3D Matrigel matrix, more closely mimicking the in vivo structural environment than 
the 2D gelatin, to induce organoid formation (Kurmann et al., 2015; Martin et al., 
1997). Extended culture in this system promoted expansion and self-organization of 
the cells into follicle-like structures (Figure 3.15A-D).  
 
Expression of mature markers (TG, TSHR, NIS) after extended culture 
Upon culture to D30 (Figure 3.16A), the follicle structures expressed markers 
indicative of maturing thyroid. These follicles were composed of NKX2-1+, PAX8+ 
cells and were epithelial in nature (E-cadherin+). TG appeared to be secreted into 
the follicle lumen, with basolateral NIS, indicating maturation (Figure 3.16B). The 
follicles expressed polarization markers (ZO1) in a pattern highly similar to adult 
mouse thyroid tissue (Figure 3.16C).  
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Figure 3.15. Effect of growth matrix on thyroid culture 
A. Experimental schematic of different culture conditions.  
B. Phase contrast micrographs showing the cell morphology of D22 cells grown on two-
dimensional gelatin coated plates or embedded in three-dimensional Matrigel from D14-D22. 
C. Flow cytometry quantification of intracellular staining for NKX2-1+ and PAX8+ cells grown in 2D 
vs. 3D culture conditions (n= 3 wells from the same differentiation). 
D. 10-day time course of follicle-forming cells (Dox D6-D7) seeded in Matrigel at D22.  
  94 
 
 
Figure 3.16. Thyroid marker expression in follicle-forming growth conditions.  
A. Experimental schematic of the extended culture conditions in Figures B and C. 
B. Immunostaining of induced cultures at D30 (Matrigel embedded). Scale bars represent 100 µm. 
C. Immunostaining for NKX2-1 and ZO1 of induced cultures at D30 (Matrigel embedded) with 
comparison to adult mouse thyroid tissue. Scale bars represent 100 µm. 
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Extended Dox Induction Enhances Thyroid Specification 
Because the 24 hr of D6-D7 Dox induction results in the derivation of both an 
NKX2-1+, PAX8- and NKX2-1+, PAX8+ population, we sought to enhance the double 
population. We found that extending the duration of D6 Dox exposure from D7 to 
D12 or D14 resulted in the majority of the cells converting to the double positive 
population, indicative of specified thyroid (Figure 3.17A,B). This effect was stable to 
D22, leading to the derivation of an 80-90% TP population (Figure 3.17C,D).  
 
TSH enhances growth and maturation 
We next examined the effect of TSH treatment on our derived thyroid 
progenitors. TSH stimulation resulted in morphological changes and increased the 
expression of Tg, indicating a direct influence of TSH on their growth and 
maturation (Figure 3.18A-C). 
 
Functional hormone (T4) production 
Following extended culture to D50 in maturation media containing TSH 
(Kurmann et al., 2015) (Figure 3.19A), gene expression of mature markers 
continued at high levels or further increased (Figure 3.19B). Organoids exposed to 
iodide produced T4 (Figure 3.19C,D) indicating full functional capability. Of 
particular note, Dox D6-D12 induced cultures produced T4 at a comparable level to 
the control of adult mouse thyroid tissue.   
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Figure 3.17. Effect of prolonged Nkx2-1 induction on thyroid specification 
A. Intracellular flow cytometry for populations at D22 (upper panel) 
B. Percent positive populations at D22 of NKX2-1, PAX8 quantified by flow cytometry.  
C. Comparison of double positive (NKX2-1+ and PAX+) population as a percentage of the NKX2-1+ 
population (n=4 individual differentiations) 
D. Immunostaining at D14 and D22 for thyroid markers. Scale bar indicates 100 µm. 
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Figure 3.18. Effect of TSH on TP growth and maturation. 
A. Schematic of TSH addition to the differentiation protocol. 
B. D22 phase contrast micrographs showing the cell morphologies in the different conditions.  
C. RT-qPCT results showing gene expression of thyroglobulin at D22 +/- TSH. 
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Figure 3.19. Maturation to T4 production 
A. Schematic of the maturation culture conditions for Figure 3F,G. 
B. Gene expression data of cells cultured to D50 for T4 ELISA analysis as in Figure 3D,E (n=3 wells 
from the same differentiation). 
C. T4 ELISA from D50 (Dox D6-D7) cells +/- 10 μM NaI from D40 to D50 (n=3 wells from the same 
differentiation). Mouse thyroid tissue for reference (n=2 tissue samples). 
D. D50 immunostaining for +NaI cultures corresponding with (F). Scale bar represents 100 μm. T4 
ELISA performed by Jinyoung Choi 
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Measuring iodide uptake with colorimetric assay 
Analysis of iodide uptake is another technique often used to indicate thyroid 
functionality. Iodide is an essential component of thyroid hormone synthesis and 
thyrocytes regularly uptake iodide through a series of channels. A common hurdle 
for laboratories is the radioactive components of the standard assay. Hence, we have 
adapted a colorimetric reaction technique used for the measurement of intracellular 
iodide (Figure 3.20A,B) (Waltz et al., 2010). 
Picomoles of iodide were measured according to a standard curve (Figure 
3.20B) and compared to parallel samples treated with sodium perchlorate, an 
inhibitor of NIS. Results from the FRTL5 line, used as a control and for optimization 
experiments, demonstrated efficient uptake of iodide on multiple two-dimensional 
substrates (Figure 3.20D), however the iNkx2-1-derived TPs did not demonstrate 
efficient uptake (Figure 3.20E). 
The negative results may merely be an artifact of in vitro cell culture, the two-
dimensional growth format used for these results, or slight maturation 
inadequacies. However, production of T4 is downstream of cellular iodide uptake, 
and because the iNkx2-1-derived putative thyrocytes did demonstrate production of 
T4, presumably they are capable of uptaking iodide in a manner not detected by this 
assay. Future experiments will seek to adapt this protocol to three-dimensional 
culture and adjust media components and the stage and timing of iodide exposure. 
Nonetheless, the success of this technique will be a valuable resource going forward 
in the analysis of in vitro derived thyrocyte maturation.  
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Figure 3.20. Adaptation of a non-radioactive colorimetric assay for determining cellular 
iodide uptake capacity.  
A. Schematic the reaction between As(III) and Ce(IV) catalyzed by iodide (Sandell-Kolthoff 
reaction). Adapted from (Waltz et al., 2010). 
B. Schematic of experimental workflow to perform and read assay.  
C. Standard curve of iodide concentrations used for result analysis. 
D. Results from FRTL5 line on various substrates. 
E. Results from iNkx2-1 line on gelatin with FRTL5 line as control. 
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Results V – Investigation of Essential Developmental Signaling Pathways 
Endoderm derivation and anteriorization are essential 
Next we sought to define the parameters of the robust AFE response to 
transient heterologous NKX2-1 expression. The NS-mediated anteriorization at the 
DE stage has been previously shown to be essential for lung/thyroid specification 
(Longmire et al., 2012). Progression to this stage can be tracked using the kinetics of 
several markers. Extensive co-expression of FOXA2 and SOX17 at D5 demonstrate 
efficient endoderm induction. Post-anteriorization, SOX2 is extensively expressed 
(Figure 3.21A). Interestingly, while FOXA2 increases during endoderm induction 
(Figure 3.21B), its expression drops following NS treatment (Figure 3.21A-C). This 
effect does not occur to the same extent with continuation in Activin, indicating the 
drop in expression is due to the patterning signals and not a temporal effect (Figure 
3.21C) 
Omission of NS-mediated anteriorization at the DE stage, previously shown 
to be essential for lung/thyroid specification (Longmire et al., 2012), significantly 
reduced the percentage of NKX2-1+ cells, both with the standard and induced 
protocols (Figure 3.21D). More so, we found that abbreviation of this stage resulted 
in a time-proportional reduction in the D14 NKX2-1+ cell percentage (Figure 3.21E) 
demonstrating the inductive effect of NKX2-1 overexpression is dependent on 
efficient AFE patterning. 
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Figure 3.21. Efficient specification is dependent on specific patterning of the AFE population 
A. Endoderm staining for markers of DE and AFE show efficient derivation. Scale bars represent 
200 μm. 
B. Flow cytometry data showing the induction kinetic of Foxa2+ definitive endoderm, stained using 
the hCD4 knock-in reporter. Using the Foxa2hCD4 and BryGFP reporters we were able to track the 
DE derivation through an anterior primitive streak (double positive) intermediate. When cells 
are hereafter exposed to NS treatment, expression of FOXA2 by percentage rapidly decreases 
during this 24 hr period, resulting in two populations (FOXA2High and FOXA2Neg). 
C. D5-D6 FOXAhCD4 kinetic (NS media vs. Activin). When cells remain in Activin in place of the NS 
treatment, loss of FOXA2 does not occur to the same extent, indicating this drop is in response to 
the NS treatment. 
D. Intracellular D14 flow cytometry for NKX2-1 following D5-D6 NS or Activin treatment (n=3 
independent experiments). 
E. Intracellular D14 flow cytometry plots from varying duration of the anteriorization stage 
followed by 24 hours of Dox treatment. 
 
 
 
Dual activation of FGF and BMP signaling pathways is required 
FGF2 and BMP4 have been identified as necessary and sufficient signals for 
thyroid specification in several species including mouse (Kurmann et al., 2015). 
Withdrawal of either factor resulted in a severe loss of NKX2-1+ thyroid 
specification and thyroid marker expression as well as reduced cell expansion in 
both un-induced and induced conditions (Figure 3.22A-C).  
Lastly, Dox-treated pre-endoderm-stage cells cultured in various media 
including TGF-β/BMP inhibition followed by BMP4/FGF2 stimulation did not show 
thyroid competence (Figure 3.22D). 
Taken collectively, these data demonstrate that only appropriately patterned 
AFE in conjunction with essential signaling pathways can specify at high efficiency 
to TPs in response to NKX2-1 overexpression. 
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Figure 3.22. Requirement of dual activation of specification signals.  
A. D14 RT-qPCR from induced and un-induced cells with specification factor variations. Fold 
changes relative to undifferentiated cells (n=3 wells from same differentiation). Results 
representative of three independent experiments. 
B. Flow cytometry quantification at D14 of NKX2-1+ and PAX8+ cells from cultures grown (as in Fig 
3G) with both specification factors compared to FGF2 alone. Error bars represent SD of biological 
triplicates within the same differentiation 
C. Cell counts (cells/well of a 6-well plate) harvested at D14 (same conditions as in G). 
D. Experimental schematics with results for early media variations and Dox inductions. 
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Results VI – Identification of thyroid competent anterior foregut populations 
Next we wanted to determine if the AFE contained subpopulations with 
variations in thyroid competency. We interrogated FOXA2 due to its dynamic 
expression kinetics during in vivo and in vitro foregut endoderm derivation (Fagman 
and Nilsson, 2011; Gadue et al., 2006) (Figure 3.21A-C). 
We sorted cells at the AFE stage based on FOXA2hCD4 expression, and 
replated Foxa2High and Foxa2Neg populations with or without Dox from D6-D7 
(Figure 3.23A). At D22, we found the FOXA2Neg, relative to FOXA2High, induced 
population resulted in higher numbers of NKX2-1+ and PAX8+ cells (Figure 3.23B,C) 
and higher expression of thyroid markers (Figure 3.23D).  
Differentiation to mesodermal lineages also progresses through a FOXA2 
expression kinetic. However, no thyroid specification was observed from FOXA2Low 
mesoderm treated with Dox and cultured in thyroid specification media (Figure 3.24 
A-C), indicating FOXA2 levels alone do not determine thyroid competence and 
progression to the AFE is essential.  
These results indicate the FOXA2Neg population likely acquires this unique 
stage-specific thyroid competence through sequential progression from FOXA2+ DE 
to FOXA2Neg AFE. This novel finding of thyroid specification from FOXA2- AFE may 
be useful in optimizing the differentiation protocol to target differentiation to 
increase derivation of this intermediate population, which could involve adjusting 
the timing or signals of endoderm induction or anteriorization. 
  
  106 
 
 
Figure 3.23. Efficient specification is dependent on precise modulation of BMP/FGF signaling 
and derivation of the thyroid-competent FOXA2Neg AFE population 
A. Flow cytometry sort schematic of D6 FOXA2+ AFE. 
B. Intracellular D22 flow cytometry from the sorted and induced populations shown in (C). 
Representative of three independent experiments. 
C. D22 immunostaining from FOXA2High and FOXA2Neg sorted populations. Scale bars represent 100 
µm in upper panels and 1000 μm in lower panel (composite image). 
D. D22 RT-qPCR data from the sorted populations shown in (C), with and without Dox D6-D7. Fold 
changes relative to undifferentiated cells, statistics from paired t-tests, (n=5 independent 
experiments). 
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Figure 3.24. FOXA2Low mesoderm lacks thyroid competence 
A. Experimental schematic of AFE vs. mesodermal population derivation and media used for 
specification and outgrowth. Early mesoderm at D4 (“Mesoderm” branch) was cultured +/- Dox 
for 24 hr, either in mesoderm-promoting media (DMEM+FBS) or in the thyroid specification 
media (BMP4/FGF2) for comparison to the thyroid protocol (“Endoderm” branch), also +/- Dox 
D6-D7. 
B. Flow cytometry comparison of FOXA2, BRY expression in AFE vs. mesodermal stage populations. 
C. RT-qPCR for endogenous Nkx2-1 expression for the conditions described in (E), duplicate 
samples. Fold changes were calculated relative to D0 undifferentiated cells.  
 
 
 
Results VII – RNA-Sequencing Identifies Up-Regulated Genes at Critical Stages 
Hierarchical clustering and PCA identify strong unique clustering by time point  
To gain further insights in the differential response to Nkx2-1 
overexpression, we performed RNA-Sequencing (RNA-Seq) on three populations: 
Dox-induced D1 cells (minimal competence) Dox-induced D7 cells (AFE stage, 
maximum competence) and D14 cells, Dox D6-D7 (NKX2-1-induced TPs). 
Unsupervised hierarchical clustering and Principal Component Analysis (PCA), 
demonstrated distinct transcriptional profiles by population (Figure 3.25A,B).  
 
B No Dox 
D0  
24 hr Dox 
No Dox 
24 hr Dox 
No Dox 
24 hr Dox 
cSFDM + FBS 
cSFDM + FBS 
BMP4 + FGF2 
BMP4 + FGF2 
BMP4 + FGF2 
BMP4 + FGF2 
M
e
s
o
d
e
rm
 
E
n
d
o
d
e
rm
 
D4 
D6 
A C 
F
o
ld
 C
h
a
n
g
e
 
Nkx2-1 
Endogenous 
2000
4000
6000
8000
10000
- + - + - +
Mesoderm Endoderm
FBS BMP4, FGF2
Dox
  108 
 
Projection analysis confirms strong thyroid signature  
To investigate the similarity of our populations to known cell types, we 
employed a linear-algebra method using projection scores to measure cell similarity 
based on global gene expression (Lang et al., 2014) (Pusuluri et al., 2015). D14 cells 
projected strongly on purified E13.5 mouse Nkx2-1GFP+ thyrocytes while D1 cells 
projected on mESCs, as expected (Figure 3.25C).  
Overall, these data suggest that our derived cells share a common 
transcriptional profile with in vivo thyrocytes and transient NKX2-1 overexpression 
in the course of directed mESC thyroid differentiation does not fundamentally alter 
the identity of the derived TPs. 
Analysis of genes by expression trends 
Investigation into upregulated signaling pathways revealed active BMP and 
FGF signaling at D7 and D14, again confirming the relevance of these pathways in 
thyroid specification (Figure 3.25D).  
Gene Ontology (GO) analysis showed strong segregation of processes relating 
to differentiating cells (Figure 3.26A) demonstrating the unique expression profiles 
transitioning from early differentiation to later stages specification stages.  
Additionally we compared our data set (in the form of genes which either 
decreased or increased in expression between time points) to published reference 
data sets from studies on thyroid and other relevant lineages (Figure 3.26B) 
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(Longmire et al., 2012) (Fagman et al., 2011; Herriges et al., 2012; Millien et al., 
2008). The similarity between the Nkx2-1GFP+ day 15 sorted cells from Longmire et 
al. and our genes increasing in expression was expected due to the similarity of in 
vitro protocols while the decreased overlap with RNA-Seq genes decreasing in 
expression confirms the similarity is not due to in vitro artifacts or non-specific gene 
expression. Millien et al (microarray data from the developing foregut) and Herriges 
et al (transcription factors with differential expression in distinct sub-regions of the 
lung at E13.5) showed less similarity with our data, but still more similarity with the 
genes increasing in expression over decreasing, indicating possibly slight 
enrichment with foregut or lung lineages. From the three data sets described in 
Fagman et al (E10.5 lung and thyroid microarray), the highest similarity was found 
with genes specifically enriched in the thyroid and excluded from the lung at E10.5. 
This set also showed the highest dissimilarity with genes decreasing in expression, 
which points to the specificity of the “increasing” genes as potential thyroid lineage 
markers. 
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 Figure 3.25. RNA-Sequencing data reveal strong clustering and thyroid signature 
A. RNA-Seq heat map of the top 9,088 differentially expressed genes with highest variance 
(FDR<0.05) among samples, clustered by samples (columns) and genes (rows). “Late” and 
“Early” clusters are indicated. 
B. PCA plot of RNA-Seq populations. 
C. Projection graph representing the degree of similarity (x-axis, exact match = 1) between RNA-
Seq samples (dots) and reference gene expression data sets (y-axis). 
D. Differential gene expression from RNA-Seq of selected genes involved in BMP and FGF signaling.  
Heat map and PCA plot generated by Liye Zhang, Projection plot generated by Alex Lang 
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Figure 3.26. RNA-Sequencing data analysis by gene expression trends 
A. Functional Analysis: Gene Ontology processes associated with genes with significant differential 
expression (P<0.05) between time points. Terms shown represent relevant biological processes 
of interest. Bars represent differentially expressed processes between conditions, full length of 
each bar is the combined value (stacked) of both sets. 
B. Comparison with published literature shows relative enrichments through overlap analysis. 
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Potential cell surface markers of interest identified two clusters 
We further analyzed two clusters of interest, based on their expression 
kinetics: either high at D7 and D14 (“Early”) or high at D14 only (“Late”) (Figure 
3.25A). From these two clusters, we identified potential transcriptional regulators 
and cell surface markers (CSMs) of thyroid fate (Table 3.1, 3.2). These clusters 
contain genes with potentially novel roles in thyroid development as well as genes 
previously implicated in foregut and early thyroid development both in vitro and in 
vivo (Fagman et al., 2011; Longmire et al., 2012; Millien et al., 2008). Of the “Early” 
cluster CSMs, EPHB2 and SIRPA were identified to be highly expressed in AFE, 
where nearly the entire population expressed these markers (Figure 3.27A,B). 
Interestingly, Ephb2 expression in in vivo foregut endoderm was reported recently 
(Dravis and Henkemeyer, 2011). From the “Late” cluster, reflective of a 
differentiated phenotype (Table 3.1), out of several CSMs correlating with the RNA-
Seq data, Col25a1 and Gabre were found to be enriched in both our induced and 
purified in vitro Nkx2-1mCherry+ TPs (Figure 3.28A,B). 
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Table 3.1. Transcription factors from the “Early” and “Late” clusters identified from RNA-
Sequencing.  
Relative gene expression across samples, low (blue) to high (red), is indicated. GEO accession 
number GSE92572.   
aGenes referenced in (Longmire et al., 2012). 
bGenes referenced in (Millien et al., 2008).  
cGenes referenced in (Fagman et al., 2011).   
 
D1 D7 D14 Cluster
  
Gene 
Symbol 
Gene Name 
1 2 1 2 3 1 2 3 
                Late Alx4 aristaless-like homeobox 4 
                
Late Ascl1 
achaete-scute complex homolog 1 
(Drosophila) 
                Late Atf3 activating transcription factor 3 
                Late Barx1 BarH-like homeobox 1 
                Late Bcl6a B-cell leukemia/lymphoma 6 
                
Late Cebpa 
CCAAT/enhancer binding protein (C/EBP), 
alpha 
                Late Creb3 cAMP responsive element binding protein 3 
                
Late Creb3l2a 
cAMP responsive element binding protein 3-
like 2 
                
Late Creb5 
RIKEN cDNA 9430076C15 gene; cAMP 
responsive element binding protein 5 
                Late Dach1 dachshund 1 (Drosophila) 
                Late Dlx5 distal-less homeobox 5 
                Late Ebf3 early B-cell factor 3 
                Late Ebf4 early B-cell factor 4 
                Late Ehf ets homologous factor 
                Late Elk3 ELK3, member of ETS oncogene family 
                Late Esrrgb estrogen-related receptor gamma 
                Late Ets1b E26 avian leukemia oncogene 1, 5' domain 
                Late Ets2 E26 avian leukemia oncogene 2, 3' domain 
                Late Etv1a ets variant gene 1 
                Late Fosa FBJ osteosarcoma oncogene 
                Late Fosba FBJ osteosarcoma oncogene B 
                Late Fosl2 similar to fos-like antigen 2; fos-like antigen 2 
                Late Foxc1 forkhead box C1 
                Late Foxc2 forkhead box C2 
                Late Foxe1 forkhead box E1 
                Late Foxj2 forkhead box J2 
                Late Foxp2 forkhead box P2 
                Late Gata2 GATA binding protein 2 
                Late Gata3a GATA binding protein 3 
                
Late Hand2 
heart and neural crest derivatives expressed 
transcript 2 
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                Late Hhexa,c hematopoietically expressed homeobox 
                Late Hic1 hypermethylated in cancer 1 
                
Late Hivep2 
human immunodeficiency virus type I 
enhancer binding protein 2 
                Late Hlx H2.0-like homeobox 
                Late Hoxa10 homeo box A10 
                Late Hoxa11 homeo box A11 
                Late Hoxa13 homeo box A13 
                Late Hoxb9 homeo box B9 
                Late Hoxd10 homeo box D10 
                Late Hoxd11 homeo box D11 
                Late Hoxd12 homeo box D12 
                Late Hoxd13 homeo box D13 
                Late Hsf4 heat shock transcription factor 4 
                Late Irf8 interferon regulatory factor 8 
                Late Juna Jun oncogene 
                Late Junba Jun-B oncogene 
                Late Junda Jun proto-oncogene related gene d 
                Late Klf11 Kruppel-like factor 11 
                Late Klf4a Kruppel-like factor 4 (gut) 
                Late Lhx9 LIM homeobox protein 9 
                
Late Mafba 
v-maf musculoaponeurotic fibrosarcoma 
oncogene family, protein B (avian) 
                
Late Maff 
v-maf musculoaponeurotic fibrosarcoma 
oncogene family, protein F (avian) 
                
Late Mef2aa 
similar to Myocyte enhancer factor 2A; 
myocyte enhancer factor 2A 
                Late Meis1 Meis homeobox 1 
                Late Meox1a,b mesenchyme homeobox 1 
                Late Meox2 mesenchyme homeobox 2 
                Late Nfat5 nuclear factor of activated T-cells 5 
                Late Nfiac nuclear factor I/A 
                Late Nfib nuclear factor I/B 
                Late Nfic nuclear factor I/C 
                Late Nfix nuclear factor I/X 
                Late Npas3 neuronal PAS domain protein 3 
                
Late Nr2f1 
nuclear receptor subfamily 2, group F, 
member 1 
                
Late Nr2f2 
similar to COUP-TFI; nuclear receptor 
subfamily 2, group F, member 2 
                
Late Nr3c1a 
nuclear receptor subfamily 3, group C, 
member 1 
                
Late Nr4a1 
nuclear receptor subfamily 4, group A, 
member 1 
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Late Nr4a2 
nuclear receptor subfamily 4, group A, 
member 2 
                
Late Pitx1 
paired-like homeodomain transcription factor 
1 
                Late Plagl1 pleiomorphic adenoma gene-like 1 
                Late Pou3f3 POU domain, class 3, transcription factor 3 
                Late Pou6f1 POU domain, class 6, transcription factor 1 
                Late Prrx1 paired related homeobox 1 
                Late Rara retinoic acid receptor, alpha 
                Late Rarb retinoic acid receptor, beta 
                
Late Rela 
v-rel reticuloendotheliosis viral oncogene 
homolog A (avian) 
                Late Rora RAR-related orphan receptor alpha 
                Late Rorc RAR-related orphan receptor gamma 
                Late Runx1 runt related transcription factor 1 
                Late Runx2b runt related transcription factor 2 
                
Late Rxra 
retinoid X receptor alpha; similar to retinoid 
X receptor-alpha 
                Late Scx scleraxis 
                
Late Six5b 
sine oculis-related homeobox 5 homolog 
(Drosophila) 
                Late Snai1 snail homolog 1 (Drosophila) 
                Late Snai2 snail homolog 2 (Drosophila) 
                Late Sox17 SRY-box containing gene 17 
                Late Sox5 SRY-box containing gene 5 
                Late Sox9 SRY-box containing gene 9 
                
Late Stat3 
similar to Stat3B; signal transducer and 
activator of transcription 3 
                Late Tbx2 T-box 2 
                Late Tbx4 T-box 4 
                Late Tcf21 transcription factor 21 
                Late Tead3 TEA domain family member 3 
                Late Tef thyrotroph embryonic factor 
                
Late Thra 
thyroid hormone receptor alpha; similar to 
thyroid hormone receptor 
                
Late Trps1 
trichorhinophalangeal syndrome I (human); 
similar to Trps1 protein 
                Late Tshz1 teashirt zinc finger family member 1 
                Late Tshz2 teashirt zinc finger family member 2 
                Late Twist1 twist homolog 1 (Drosophila) 
                Late Twist2 twist homolog 2 (Drosophila) 
                Late Zeb2a zinc finger E-box binding homeobox 2 
                
Late Zic1 
similar to Zic protein; zinc finger protein of 
the cerebellum 1 
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Early Arnt2 
aryl hydrocarbon receptor nuclear 
translocator 2 
                Early Bach2 BTB and CNC homology 2 
                Early Evx1 even skipped homeotic gene 1 homolog 
                Early Gata4 GATA binding protein 4 
                
Early Hand1 
heart and neural crest derivatives expressed 
transcript 1 
                
Early Heyl 
hairy/enhancer-of-split related with YRPW 
motif-like 
                
Early Hivep1 
human immunodeficiency virus type I 
enhancer binding protein 1 
                Early Hoxb8c homeo box B8 
                Early Irx5c Iroquois related homeobox 5 (Drosophila) 
                Early Isl1a,c ISL1 transcription factor, LIM/homeodomain 
                Early Mef2c myocyte enhancer factor 2C 
                
Early Meis3 
similar to Myeloid ecotropic viral integration 
site-related gene 2; Meis homeobox 3 
                
Early Nfatc1 
nuclear factor of activated T-cells, 
cytoplasmic, calcineurin-dependent 1 
                
Early Nfatc4 
nuclear factor of activated T-cells, 
cytoplasmic, calcineurin-dependent 4 
                Early Nfe2 nuclear factor, erythroid derived 2 
                Early Nkx2-1a NK2 homeobox 1 
                
Early Nr4a3 
nuclear receptor subfamily 4, group A, 
member 3 
                Early Pbx2 pre B-cell leukemia transcription factor 2 
                
Early Pbx3 
similar to PBX3a; pre B-cell leukemia 
transcription factor 3 
                Early Prox1 prospero-related homeobox 1 
                Early Smad3a MAD homolog 3 (Drosophila) 
                Early Smad5 MAD homolog 5 (Drosophila) 
                Early Tfap2a transcription factor AP-2, alpha 
                
Early Zfpm1 
zinc finger protein, multitype 1; similar to 
FOG 
                Early Zhx1 zinc fingers and homeoboxes 1 
                Early Zkscan3 zinc finger with KRAB and SCAN domains 3 
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Table 3.2. Putative cell surface markers factors from the “Early” and “Late” clusters identified 
from RNA-Sequencing. 
Relative gene expression across samples, low (blue) to high (red), is indicated. GEO accession 
number GSE92572.   
aGenes referenced in (Longmire et al., 2012). 
bGenes referenced in (Millien et al., 2008).  
cGenes referenced in (Fagman et al., 2011).   
 
D1 D7 D14 
Cluster 
Gene 
Symbol 
Gene Name 
1 2 1 2 3 1 2 3 
                
Late Abca1a 
ATP-binding cassette, sub-family A 
(ABC1), member 1 
                Late Acvr1 activin A receptor, type 1 
                Late Aqp1 aquaporin 1 
                
Late Asic2 
amiloride-sensitive cation channel 1, 
neuronal (degenerin) 
                Late Axl AXL receptor tyrosine kinase 
                
Late Boc 
biregional cell adhesion molecule-
related/down-regulated by oncogenes 
(Cdon) binding protein 
                
Late Cacna1d 
calcium channel, voltage-dependent, L 
type, alpha 1D subunit 
                Late Cd81 CD81 antigen 
                Late Clca1 chloride channel calcium activated 1 
                Late Cldn11 claudin 11 
                Late Col25a1a collagen, type XXV, alpha 1 
                
Late Enpp5 
ectonucleotide 
pyrophosphatase/phosphodiesterase 5 
                Late Epha3 Eph receptor A3 
                Late Epha7 Eph receptor A7 
                Late Fgfrl1 fibroblast growth factor receptor-like 1 
                
Late Gabrea 
similar to gamma-aminobutyric acid 
(GABA-A) receptor, subunit epsilon; 
gamma-aminobutyric acid (GABA) A 
receptor, subunit epsilon 
                
Late Gria1 
glutamate receptor, ionotropic, AMPA1 
(alpha 1); similar to Glutamate receptor, 
ionotropic, AMPA1 (alpha 1) 
                
Late Gria2 
glutamate receptor, ionotropic, AMPA2 
(alpha 2) 
                
Late Gria4 
glutamate receptor, ionotropic, AMPA4 
(alpha 4); hypothetical protein 
LOC100044208 
                Late Grik4 glutamate receptor, ionotropic, kainate 4 
                
Late 
Hs3st3b
1 
heparan sulfate (glucosamine) 3-O-
sulfotransferase 3B1 
                Late Itga1 integrin alpha 1 
                Late Itga11 integrin alpha 11 
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                Late Itga8 integrin alpha 8 
                Late Itga9 integrin alpha 9 
                Late Itgav integrin alpha V 
                Late Itgb1 integrin beta 1 (fibronectin receptor beta) 
                
Late Kcna6 
potassium voltage-gated channel, shaker-
related, subfamily, member 6 
                
Late Kcnc1 
potassium voltage gated channel, Shaw-
related subfamily, member 1 
                
Late Kcnd2 
potassium voltage-gated channel, Shal-
related family, member 2 
                
Late Kcnd3 
potassium voltage-gated channel, Shal-
related family, member 3 
                
Late Kcne4 
potassium voltage-gated channel, Isk-
related subfamily, gene 4 
                
Late Kcnj8 
potassium inwardly-rectifying channel, 
subfamily J, member 8 
                
Late Kcnma1 
potassium large conductance calcium-
activated channel, subfamily M, alpha 
member 1 
                
Late Kcnq3a 
potassium voltage-gated channel, 
subfamily Q, member 3 
                
Late Ntrk2 
neurotrophic tyrosine kinase, receptor, 
type 2 
                
Late Ntrk3 
neurotrophic tyrosine kinase, receptor, 
type 3; similar to neurotrophic tyrosine 
kinase, receptor, type 3 
                Late Osmra oncostatin M receptor 
                
Late P2rx4 
purinergic receptor P2X, ligand-gated ion 
channel 4 
                
Late Pam 
peptidylglycine alpha-amidating 
monooxygenase 
                Late Pcdh10 protocadherin 10 
                Late Pcdh18 protocadherin 18 
                Late Pcdh7a protocadherin 7 
                Late Pcdh9a protocadherin 9 
                
Late Pdgfra 
platelet derived growth factor receptor, 
alpha polypeptide 
                
Late Pdgfrb 
platelet derived growth factor receptor, 
beta polypeptide 
                Late S1pr3 sphingosine-1-phosphate receptor 3 
                
Late Scara5c 
scavenger receptor class A, member 5 
(putative) 
                Late Sgce sarcoglycan, epsilon 
                Late Sgms2 sphingomyelin synthase 2 
                
Late Slc24a4 
solute carrier family 24 
(sodium/potassium/calcium exchanger), 
member 4 
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Late Slc2a10 
solute carrier family 2 (facilitated glucose 
transporter), member 10 
                
Late Slc2a9 
solute carrier family 2 (facilitated glucose 
transporter), member 9 
                Late Slc38a3 solute carrier family 38, member 3 
                
Late Slc4a4a,c 
solute carrier family 4 (anion exchanger), 
member 4 
                
Late Slc6a1 
solute carrier family 6 (neurotransmitter 
transporter, GABA), member 1 
                Late Tenm2 odd Oz/ten-m homolog 2 (Drosophila) 
                
Late Tgfbr2 
transforming growth factor, beta receptor 
II 
                
Late Trpc4 
transient receptor potential cation 
channel, subfamily C, member 4 
                Early Amfr autocrine motility factor receptor 
                
Early Atp2b4a 
ATPase, Ca++ transporting, plasma 
membrane 4 
                
Early Cd47 
CD47 antigen (Rh-related antigen, 
integrin-associated signal transducer) 
                
Early Cdon 
cell adhesion molecule-related/down-
regulated by oncogenes 
                Early Ephb2 Eph receptor B2 
                Early Ephb3 Eph receptor B3 
                Early Flt1 FMS-like tyrosine kinase 1 
                
Early Grik5 
glutamate receptor, ionotropic, kainate 5 
(gamma 2) 
                Early Hbegf heparin-binding EGF-like growth factor 
                
Early Itga5 
integrin alpha 5 (fibronectin receptor 
alpha) 
                Early Itgb5a integrin beta 5 
                
Early Kcnmb4 
potassium large conductance calcium-
activated channel, subfamily M, beta 
member 4 
                Early Kdr kinase insert domain protein receptor 
                Early Npffr2 neuropeptide FF receptor 2 
                
Early P2rx6 
purinergic receptor P2X, ligand-gated ion 
channel, 6 
                
Early Ror2 
receptor tyrosine kinase-like orphan 
receptor 2 
                
Early Scn7aa 
sodium channel, voltage-gated, type VII, 
alpha 
                
Early Sdcbp 
similar to syntenin; syndecan binding 
protein 
                Early Sirpa signal-regulatory protein alpha 
                
Early Slco3a1 
solute carrier organic anion transporter 
family, member 3a1 
                Early Tenm3 odd Oz/ten-m homolog 3 (Drosophila) 
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Figure 3.27. Validation of select cell surface markers from the “Early” cluster 
A. RT-qPCR validation data of cell surface markers identified in the “Early” cluster. 
B. Flow cytometry data corresponding with (A).  
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Figure 3.28. Validation of select cell surface markers from the “Late” cluster 
A. RT-qPCR validation data of cell surface markers identified in the “Late” cluster (n=2 independent 
experiments). 
B. Further gene expression analysis of select targets from (G) with purified Nkx2-1mCherry+ from the 
thyroid protocol for validation (n=3 independent experiments).  
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Table 3.3. "Late" Cluster GSEA Analysis 
GO and KEGG pathways enriched in the “late” cluster group of genes. 
GSEA analysis performed by Maciej M. Kańduła 
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Results IIX – The Stage-Specific Effect May be Governed by a Bistable Switch 
Theoretical modeling of a bistable system 
The central observation underlying our work is that activation of an Nkx2-1 
transgene at different stages during thyroid directed differentiation results in a 
wide percentage range of endogenous NKX2-1+ TPs on D14 (Figure 3.4C). As NKX2-
1 is known to bind its own promoter (Boggaram, 2009) and almost all cells are 
transgene NKX2-1+ post-Dox induction (Figure 3.4F), the behavior of the system 
implies the existence of an AFE stage-specific, positive feedback loop at the Nkx2-1 
locus. This is further supported by the immediate activation of the endogenous 
Nkx2-1 expression at the Dox D6-D7 condition (Figure 3.4D). Based on these data, 
we modeled the D6-D7 cell response to the Dox pulse as a bistable switch (Ferrell, 
2012), where the two states are “On” and “Off” expression of endogenous Nkx2-1 
(Figure 3.29A-C). Overall, this model could qualitatively reproduce our basic 
experimental observations suggesting that a time-dependent bistable switch may 
underlie the effect of transgene overexpression on cell fate decisions during 
directed differentiation of PSCs. 
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Figure 3.29. Modeling cell fate decisions in a bistable system. 
A. Bistable model: A protein that cooperatively binds its own promoter leads to bistable switch. 
B. Percentage of high-protein expressing cells in Monte-Carlo simulations for three pulse lengths of 
protein expression. Results were calculated using 1000 simulations in each condition. 
C. Stochastic trajectories of protein number as a function of time in the absence of pulsing (main 
figure) and in the presence of a long pulse (inset). Colored lines show stochastic trajectories that 
successfully activate the Nkx2-1 feedback loop (purple lines) or fail to activate (red lines). The 
dashed line indicates the time the basal transcription rate was turned off in all simulations. 
Bistability modeling and explanation generated by Pankaj Mehta  
 
Simple mathematical model for bistable switch 
The experimental data text is consistent with the idea that Nkx2-1 positively 
regulates its own expression, giving rise to a bistable switch. To demonstrate this, 
we constructed a simple model of a genetic switch consisting of a gene that 
produces a protein that can bind its own promoter and increase gene expression 
(Figure 3.29A). When the feedback loop is cooperative, this molecular architecture 
can give rise to bistability, with two stable steady-states possible: (i) a low-
expression steady-state where the positive feedback loop is off and proteins are 
expressed at low levels and (ii) a high-expression steady-state where the positive 
feedback loop is turned-on and proteins are expressed at high levels (Ferrell, 2002; 
Maamar and Dubnau, 2005; Mehta et al., 2008; Tyson et al., 2003). 
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Mathematically, we represent the deterministic dynamics of such a bistable 
switch using a simple differential equation for the number of mRNA molecules, m, 
and the number of protein molecules, p: 
𝑑𝑚
𝑑𝑡
=  𝛼𝑝𝑢𝑙𝑠𝑒(𝑡) +  𝛼0 +
𝑎𝑚𝑝
𝑞
𝑝𝑞 + 𝐾𝑑
𝑞 − 𝜏𝑚
−1𝑚 
𝑑𝑝
𝑑𝑡
=  𝑎𝑝𝑚 − 𝜏𝑝
−1𝑝 
 
with αpulse(t) the generally (time-dependent) transcription rate from the 
pulsing construct, α0 the basal transcription rate, am the maximal transcription 
rate due to the positive feedback loop, Kd the half-maximal protein 
concentration for the positive feedback loop to turn on, q the Hill coefficient 
describing cooperative binding, τm the mRNA lifetime, ap the rate at which 
proteins are translated from an mRNA molecule, and τp the protein lifetime. For 
all simulations, we take (where rates are in units of molecules per hour) α0 = 
0.5, am = 5, ap = 20. Additionally, τ
p = 6hr, τm = 0.5hr, q = 3, and Kd = 150. 
Furthermore, we assume there is a finite time window during which the cell can 
switch to high to a protein state. Very little is known about how this occurs at 
the molecular level. Inspired by measurements of the transition to competence 
in the bacteria Bacillus subtilis (Maamar and Dubnau, 2005; Maamar et al., 
2007), we model this process by assuming that the basal transcription rate is 
turned off after a critical time cutoff, t = 25hr so that α0 = 0.5θ(tcutoff − t), 
where θ(t) is the Heaviside function. We emphasize that this is just one of many 
  126 
ways that this regulation could occur and our results do not depend strongly on 
this choice. To model pulsing for a duration tpulse, we use apulse = 4 ∗ θ(t −
tpulse). 
One can easily verify that with this choice of parameters, the dynamics are 
bistable with critical concentration pcrit ≈ 102 separating the low-expression and 
high-expression fixed points. When p < pcrit, the cell is attracted to a low-expression 
fixed point. However, when p >  pcrit, cell are attracted to a high expression state. 
Due to stochastic effects resulting from low number of molecules, cells can 
transition between these steady-states. 
To understand the stochastic switching dynamics, we performed a stochastic 
simulation of gene expression dynamics for this system using Gillespie’s algorithm 
(Gillespie, 1977; Mehta et al., 2008). We considered three distinct conditions: (i) no 
pulse where tpulse = 0=0, (ii) short pulses where tpulse = 2hr, and (iii) a long pulse 
where tpulse = 24hr. For each of these conditions, we performed 1000 simulations 
and calculated the fraction of cells with high protein expression (p >  pcrit) at t = 100hr 
(Figure 3.29B). As expected, the fraction of high-expression cells increased with the 
pulse duration. We also examined the time traces for cells that switched or did not 
switch in both the pulsed and non-pulsed conditions, representative traces are 
shown (Figure 3.29C). 
As shown in Figure 3.29B, although a certain percentage of cells is expected 
to reach the “On” state without an exogenous NKX2-1 pulse, this percentage could 
be increased by short or long NKX2-1 pulses. Figure 3.29C simulations exemplify 
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this effect, as cells displayed heterogeneous behaviors with some cells reaching the 
“On” expression state (purple lines) and others reaching the “Off” expression state in 
all conditions. On the other hand, the “On” expression state is favored in the pulsed 
condition and it is achieved faster than in the non-pulsed condition. 
 
 
Discussion 
PSC-based systems hold great promise for the mass production of 
transplantable, clinically relevant cell types and for in vitro modeling of complex 
disease states. Currently, a major roadblock to achieving these goals is the poor or 
variable differentiation efficiency of many differentiation protocols. This study used 
developmental stage-specific overexpression of a single TF, NKX2-1, to: a) 
investigate how cell competence changes in a dynamic, developmentally-relevant 
system and b) improve the efficiency of TP specification. 
These results demonstrate the inductive effect of NKX2-1 is restricted to a 
singular stage of competence contingent upon several synergistic parameters 
(FOXA2 levels, duration of anteriorization, and BMP4/FGF2 signaling), implying that 
AFE-staged cells possess a unique epigenetic status allowing for robust conversion 
to thyroid. Respiratory lineages were not derived as indicated by insignificant 
numbers of SPC+ cells and the only presumed lung marker with high levels of 
expression (Sftpb) is expressed in both adult mouse (Figure3.10A,B) and human 
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thyroid (http://gtexportal.org/home/gene/SFTPB). We presume that the absence of 
Wnt agonists, an important signal for lung specification  
(Goss et al., 2009; Harris-Johnson et al., 2009; S. X. L. Huang et al., 2013), is 
the major reason for the paucity of respiratory lineages following NKX2-1 
overexpression in our system. 
This study also achieved the practical goal of highly efficient thyroid 
differentiation. Our data indicate the majority of the derived progenitors acquired a 
thyroid identity comparable to their in vivo counterparts and importantly, their 
progeny gave rise to follicular-like structures in a 3D environment, expressed genes 
of thyroid hormone biosynthesis at levels comparable to adult thyroid, and 
produced high levels of T4 hormone. Overall, it appears that brief NKX2-1 
exogenous expression during a well-defined window of maximum thyroid 
competence is sufficient to dramatically increase the yield and robustness of PSC-
derived thyroid specification and differentiation. Although a similar end-stage result 
has been previously reported through direct reprogramming of mESCs (Antonica et 
al., 2012), our approach delves into the mechanistic aspects of thyroid fate decisions 
and competence at a developmentally relevant stage. Further work is needed to 
define whether the thyrocyte-like cells produced downstream in our system are 
functionally equivalent to the progeny of purified bona fide TPs (Kurmann et al., 
2015). 
This work has provided knowledge on the thyroid competence of 
endodermal populations and has opened up additional questions. We now know the 
  129 
majority of the AFE-stage population do indeed possess a level of thyroid 
competence, since overexpression of Nkx2-1 can robustly convert only cells at this 
stage. However, this population does not appear to be optimally targeted for thyroid 
specification in the standard differentiation (no Dox) protocol, which is relatively 
inefficient. We have yet to discover the lacking components to equate the two 
systems. It is possible there is a need for adjustments in endoderm patterning, 
additional specification signals, or for repression of competing lineages.  
This system can also be useful as a discovery tool in the absence of lineage-
specific reporters. Analysis of the RNA-Seq has identified both CSMs as well as 
potential regulators of thyroid fate in AFE and early TPs. Some of the TFs identified 
(Irx5, Hoxb8, Isl1) have been involved in mouse foregut and thyroid development 
(Millien et al., 2008; Westerlund et al., 2008), while others such as PROX1 have been 
implicated in human thyroid disease (Ishii et al., 2016). Future PSC-based and in 
vivo studies will unravel the thyroid-related function of select TFs during thyroid 
specification and development.  
Our theoretical model proposes a bistable positive feedback loop as the 
underlying mechanism to describe the endogenous Nkx2-1 locus activation at the 
AFE stage leading to subsequent stabilization of the core TF network, establishing 
thyroid identity. Future work will focus on experimental validation of the model and 
investigate the possibility that bistable switches controlling bifurcation dynamics in 
cell fate decisions (Loh et al., 2014) can lead to the development of highly efficient 
and robust protocols of general applicability.  
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CHAPTER IV - LENTIVIRUS ENGINEERING FOR ALTERNATIVE 
OVEREXPRESSION SYSTEM 
Introduction 
Certain follow-up studies on the compelling results of thyroid derivation 
from the iNkx2-1 line require an approach with enhanced analysis opportunities. 
While the engineered TetO system offered clear advantages (induction efficiency, 
lack of silencing), it also had drawbacks. First, the results were limited to a single 
mESC line, opening the question of reproducibility. Second, the iNkx2-1 had neither 
a reporter for transgene induction, nor a reporter for endogenous lineage-specific 
genes (Nkx2-1 or Pax8). Additionally, at this current stage, a known cell surface 
marker specific to thyroid progenitors suitable for their purification has yet to be 
identified. The ability to sort the directly induced populations and/or purify the 
target lineage (thyroid) would greatly aid in more mechanistic studies that are 
currently complicated by heterogeneous populations. Furthermore, future studies 
investigating the role of bistability and its applications in this system would require 
sorting based on the expression levels of the induced transgene. To this end, we 
have developed two additional systems: a similar TetO transgenic line with an 
additional Nkx2-1 transgene reporter, and lentiviral vectors containing a Dox-
inducible lentiviral construct. 
Methods 
To generate a TetO iNkx2-1-GFP reporter line (iNkx2-1F2A-eGFP), a bicistronic 
transgene containing Nkx2-1 and eGFP separated by a F2A peptide, which self-
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cleaves and allows simultaneous expression of both genes (Szymczak and Vignali, 
2005), was targeted using the ICE system (Iacovino et al., 2011a) (Figure 4.1A). The 
F2A peptide is self-cleaving and allows simultaneous expression of both genes 
(Szymczak and Vignali, 2005). Clones containing only an eGFP transgene were also 
targeted, for use as experimental controls.  
Cytogenetic analysis was performed on 20 G-banded metaphase cells from 
the selected iNkx2-1F2A-eGFP clone. All 20 cells demonstrated an abnormal male 
karyotype with a balanced translocation between chromosome 1 at band D and 
chromosome 5 at band G2. 2 cells demonstrated the loss of the Y chromosome, 
which may represent an artifact of culture and is common in mESC cell lines. 
Although this clone was used for the initial experiments described here as a proof of 
concept, alternative clones with a normal karyotype will be used for future 
experiments. 
Results 
Targeted clones (Figure 4.1A) were analyzed for transgene efficiency by 
immunostaining and flow cytometry after 24 hr Dox exposure. One clone with 
efficient co-expression of Nkx2-1 and eGFP after Dox induction (~85%) was 
selected and used for subsequent experiments (Figure 4.1B,C). In this clone, we 
observed both nuclear NKX2-1 and eGFP. This posed an issue because, while NKX2-
1 translocates to the nucleus, only nuclear eGFP implicated an NKX2-1-eGFP fusion 
protein that could potentially interfere with NKX2-1 DNA-binding activity. From 
sequencing of the donor plasmid and genotyping of the clone, the F2A peptide 
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sequence is present and in-frame with Nkx2-1 and eGFP. A possible explanation is 
inefficient F2A cleavage, as the F2A has been shown in multiple studies to have a 
low cleavage efficiency relative to other 2A peptides (J. H. Kim et al., 2011; Y. Wang 
et al., 2015). 
This iNkx2-1F2A-eGFP clone, when induced with Dox from D6-D7, responded 
similarly to the iNkx2-1line previously described (Dame et al., 2017) and exhibited a 
high percentage of sustained NKX2-1+ cells at later time points (Figure 4.1D), 
indicative of conversion to the thyroid lineage. Importantly, this demonstrates the 
reproducibility of Nkx2-1-driven thyroid conversion by confirming the previous 
findings in a secondary cell line. 
In addition to the iNkx2-1F2A-eGFP lines, we have also been creating lentiviral 
vectors for an alternative method of overexpressing Nkx2-1. The engineered 
plasmid, containing both Nkx2-1 and tdTomato under control of the inducible 
TetOmCMV promoter (Figure 4.2A), was packaged into a lentiviral vector. 
Transduction with this vector and an rtTA-expressing vector in mESCs resulting in 
stably transduced lines demonstrating high efficiency induction in response to 24 hr 
Dox exposure. These clones, however, while they were effectively induced at the 
pluripotent stage, demonstrated low efficiency at later stages of differentiation, DE 
and AFE (data not shown), indicating silencing during the course of differentiation, a 
known hurdle. Because of this, these lentiviral vectors may be more suitable for 
transduction over the course of directed differentiation.  
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Figure 4.1. Development and characterization of the iNkx2-1eGFP reporter line 
A. Schematic of plasmid integration into the HPRT locus. 
B. Fluorescent expression of transgenic eGFP and immunostaining for NKX2-1. 
C. Flow cytometry for NKX2-1eGFP with and without 24 hr of prior Dox exposure. 
D. D20 flow cytometry for NKX2-1eGFP with and without AFE-stage Dox induction. 
A-D results collected by Drew Bergman (Ikonomou Lab undergraduate student) 
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Figure 4.2. Development and characterization of lentiviral vectors 
A. Plasmid map for TetOmCMV-Nkx2.1-F2A-tdTomato vector in pHAGE2 backbone. 
B. Stably transduced clones expressing NKX2-1 24 hr following Dox exposure. 
A,B results collected by Steven Cincotta (Ikonomou Lab undergraduate student)  
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Discussion 
Future work in the iNkx2-1F2A-eGFP reporter line will involve the 
characterization of the generated iNkx2-1F2A-eGFP clones to identify a clone with 
normal karyotype and efficient F2A cleavage and the targeting of other cell lines to 
overexpress factors of the core thyroid transcription factor network. Future work 
with the lentiviral overexpression vectors will seek to optimize their use in directed 
differentiation protocols. Because of large-scale silencing occurring from the 
pluripotent stage through differentiation, it may be necessary to identify a suitable 
intermediate stage to transduce differentiating populations. However, this method 
would necessitate a high-efficiency transduction rate, whereas the EB culture 
system (difficult to infect) impedes this feasibility. Because of this, the lentiviral 
vectors may be more suitable for use with the human PSC differentiation system, 
which relies on monolayer culture for the derivation of DE and AFE.  
These tools, capable of isolating induced or resulting populations in various 
contexts and alternative cells lines, will be used for mechanistic studies and more 
specific downstream characterization of resulting populations. With the transgene 
reporter in the iNkx2-1GFP line, D7 induced cells can be sorted based on NKX2-1 
expression levels, which could resolve further questions regarding thyroid 
competent populations by eliminating confounding variables. Later stage specified 
populations (D14 or D22) could also be sorted when the lentiviral system when 
used in conjunction with a reporter line (Nkx2-1GFP or Nkx2-1mCherry) which will aid 
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in characterization of these cells, identification of thyroid-specific markers, and 
functional studies or possibly disease modeling. 
These lines could also be used to experimentally demonstrate bistability as a 
model of endogenous Nkx2-1 locus activation at the AFE stage leading to a thyroid 
identity (Figure 3.29) by sorting based on levels of NKX2-1 following Dox-induction. 
This method could be applied to test other theoretical bistable switches controlling 
bifurcation dynamics in cell fate decisions (Loh et al., 2014) which could lead to the 
development of robust directed differentiation protocols in under-investigated 
lineages. 
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CHAPTER V - PREPARATION OF AN IN VIVO MODEL FOR NKX2-1 FOREGUT 
OVEREXPRESSION 
 
Introduction 
To further understand the dynamic competence of endodermal lineage 
progenitors, we have developed an in vivo system analogous to our in vitro work. 
Other research studies have used transcriptional overexpression at various 
developmental stages in the mouse to achieve conversion to endodermal lineages 
such as intestinal (Silberg et al., 2002), or pancreatic (Heller et al., 2001; K. A. 
Johansson et al., 2007; Kawaguchi et al., 2002; Schwitzgebel et al., 2000) as well as 
in other model organism systems such as drosophila (Halder et al., 1995) and the 
chick (Grapin-Botton et al., 2001).  
From the iNkx2-1 in vitro system, we established that cells at the anterior 
foregut stage of development are highly susceptible in their response to Nkx2-1 
overexpression and can be converted to thyroid progenitor cells. Thus, we are 
interested in establishing the potential in vivo counterparts of our in vitro derived 
competent cells. To study what endodermal populations in vivo are capable of 
responding to Nkx2-1 overexpression, we have been engineering a mouse model 
specifically designed to spatially and temporally manipulate expression of Nkx2-1. 
To this end, we have crossed an (TetO)Nkx2-1-mouse (Maeda et al., 2012) to a 
Foxa2rtTA mouse to study the pan-endodermal effects of Nkx2-1 ectopic expression 
induced at the AFE stage (Figure 5.1A). Follow up experiments will also include 
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additional driver strains Shhcre and Cdx2cre for increased localization of Nkx2-1 
expression to the anterior (Goss et al., 2009; Harris et al., 2006; Litingtung et al., 
1998) and posterior foregut, respectively. Shh is known to be expressed throughout 
the developing foregut endoderm early in development, including the lung 
primordium and with the possible exception of the thyroid domain (Bellusci et al., 
1997; Fagman et al., 2004; Roberts et al., 1995) while Cdx2 demarcates posterior 
endoderm. These crosses will include the floxed rtTA mouse (Figure 5.1B) since 
they are not currently engineered to directly express the rtTA protein (Rawlins and 
Perl, 2012). 
 
 
Results 
Thus far, we have developed a mouse model to target Nkx2-1 overexpression 
to the foregut (Figure 5.2A). For future analysis of induced embryos, we will use IHC 
to look at NKX2-1 and FLAG expression and thyroid and lung lineage markers 
(thyroid: PAX8, TG; lung: SPC, SPB, CC10) to provide evidence of downstream 
lineage specification. Additionally, IHC for other endodermal markers (liver: AFP, 
ALB; pancreas and posterior stomach: PDX1) in treated vs. untreated mice will be 
informative to whether other organ specification is disrupted in our model. We will 
analyze stained sections various time points (Figure 5.2B) and use fluorescent 
microscopy to visualize and image patterns of expression for each gene.  
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Figure 5.1. Development of a mouse model for regional and temporal-specific ectopic 
expression of Nkx2-1 
A. Schematic of the foregut and regions of organ specification with transcription factor expression 
zones.  Note: Shh expression is excluded in the early thyroid domain (Fagman et al., 2004). 
B. Schematic of the mouse models developed through crosses for controlled ectopic expression of 
Nkx2-1. 
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Figure 5.2. Mouse strains and experimental schematic.  
A. Genotyping of the (Tet0)Nkx2-1 and Foxa2rtTA strains. 
B. Experimental schematic for Dox treatment (yellow) and analysis time points (red arrows). 
 
 
 
 
Discussion 
From this study, we expect that correlating in vivo populations will respond 
similarly to our in vitro model of thyroid conversion, and some effect of Nkx2-1 
overexpression will be identifiable. The FOXA2+ endoderm may highlight the full 
region of competence and possibly resolve borderlines of any expanded Nkx2-1+ 
domains. We anticipate the Shh+ foregut endoderm will be at least partially 
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converted into thyroid or lung lineages. In contrast, we expect that the Cdx2+ 
posterior endoderm population will be refractory to fate conversion. In vivo, there 
are additional cell-cell interactions, and signals from the surrounding mesenchyme 
which will be competing with directional cell fate signals. For example, Foxa2, 
Bmp4, Wnt, and Retinoic acid (Bayha et al., 2009) gradients coordinate to specify 
the organ domains on an anterior-posterior and ventral-dorsal axis (liver, pancreas, 
lung, thyroid, parathyroid). These signaling interactions may interfere with Nkx2-1-
induced specification in some endodermal regions. Additionally, we are interested 
to analyze the derived tissue for thyroid vs. lung markers to see which lineage is 
preferentially induced in vivo. The on/off induction response of this mouse model 
does have limitations and most likely will not be as sensitive as the in vitro system, 
i.e. the Nkx2-1 gene may take a longer period of time to be expressed in all Cre-
expressing cells and the off kinetics will be slower as well, because the Dox must be 
metabolized out of the body before the system will shut off. This means we will not 
be able to directly compare our in vivo results to our in vitro data from a temporal 
standpoint, and we must understand the kinetics of our mouse system before fully 
interpreting our results. However, despite this, we expect this system will generate 
comparable and interesting results. 
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CHAPTER VI - GENERAL DISCUSSION 
This work has overall demonstrated the usefulness of overexpression 
systems with their informative contributions to developmental studies. This work 
has aided in the resolution of developmental parameters (endoderm patterning and 
specification) involved in thyroid specification and created a high-efficiency PSC-
based system to derive thyrocytes described. Furthermore, we were able to drive 
our derived thyrocytes to a functionally mature stage, leading to possibilities for a 
platform for drug testing or disease modeling. We also employed mathematical 
modeling to create a potentially generalizable model for overexpression systems 
leading to a stable specification outcome.  
 The next steps stemming from this project (alternative overexpression 
systems and the in vivo analogous mouse model) will create additional 
opportunities for interrogating thyroid specification and early development, as well 
as delving further into aspects such as endodermal competence and modeling 
potential.  
 The results from this work also raise more questions regarding the 
conversion trajectory from endoderm to thyroid. While a large percentage was 
converted to thyroid (NKX2-1+, PAX8+), another population did not co-express the 
thyroid-indicative transcription factors (NKX2-1+, PAX8-). While this population is 
not thyroid, we were unable to identify it as another NKX2-1+ lineage (lung or 
neuronal), leading us to hypothesize it has stalled at a partially converted fate. While 
this population seemed to be targeted for full conversion with extended Dox 
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treatment, the 24 hr of overexpression appeared to be insufficient in fully 
converting this population. It is unknown if the fully and partially converted 
populations have the same or different endodermal origins, which might explain the 
difficulties in converting this population. It is also unknown if the partially-
converted population is heterogeneous, or if there is a stable intermediate stage 
where this partially-specified fate is stalled. The latter, introducing a secondary 
energy barrier, could explain the need for a more intense signal to move them to a 
fully converted state. Because of this, for studies simply focused on the high-
efficiency derivation of functional thyrocytes, the extended Dox condition would be 
recommended for use. The short pulse of Dox, however, worked well for our studies 
resolving nuances at the AFE stage and derived putative thyrocytes expressing the 
fully array of thyroid markers at a percentage large enough for robust analysis.  
There are multiple ways this work could be translated to future clinical 
therapies. The first is that a similar inducible system could be developed in a human 
iPSC model system. Theoretically, a model such as this could be used to derive 
human thyrocytes at high efficiency, if the two protocols behave similarly in terms 
of thyroid competency and ensuing conversion. However, safety concerns regarding 
the use of genetically engineered cells in clinical trials are a barrier. Alternatively, 
non-integrating methods of gene expression manipulation systems are more and 
more becoming feasible options (see introduction). These methods could also be 
applied directly in vivo. If an in vivo population can be identified amenable to thyroid 
conversion, gene therapy techniques could be used to convert a small population to 
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functional thyrocytes and thereby restore the body’s capability for synthesizing 
thyroid hormone. The mouse model may also be highly informative in the initial 
identification of candidate target populations.  
The knowledge gained from this work will be immediately helpful in 
optimizing future directed differentiation methods in human iPSCs without 
inducible systems as well. From this work, we now understand the majority of cells 
at the AFE stage do possess some level of thyroid competence. Currently, however, 
the AFE stage in the mouse and human protocols do have some differences. In both 
systems, FOXA2 levels are high at the DE stage, while at the AFE stage, FOXA2 levels 
have decreased in the mouse and remain high in the human. Since this work has 
demonstrated that the FOXA2Neg AFE population possesses the strongest thyroid 
competence, the human protocol may need to be adjusted to optimize derivation of 
this population. It is possible this could be accomplished by changing the timing or 
the signals involved at the anteriorization stage.  
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APPENDIX I - LUNG PRIMORDIUM NKX2-1 LINEAGE TRACE 
Introduction 
 An implicit hypothesis in the field of lung development biology is that the 
entirety of the lung epithelium originated from the primordial population of NKX2-
1+ cells. This small group of cells is specified at E9 and the current thought in the 
field is that the diverse array of the lineages found in the adult lung differentiates 
from this population as the lung develops (Figure a1.1A). These include both NKX2-
1+ lineages (type II alveolar epithelial cells, basal cells, and club cells) and NKX2-1- 
lineages (type I alveolar epithelial cells, ciliated cells, goblet cells, and 
neuroendocrine cells). However, this hypothesis has not formally been tested in an 
appropriately sensitive system, and there remains the possibility that other cells 
outside of the E9 primordial population contribute to the final epithelial lineages of 
the adult lung.  
  Several studies thus far have examined lineage tracing in the lung. Two 
studies utilized a constitutive Nkx2-1Cre (Q. Xu et al., 2008) crossed with the ROSAmT-
mG reporter mouse (Muzumdar et al., 2007) to demonstrate the NKX2-1+ origins of 
two specific lineages, neuroendocrine cells (H. Song et al., 2012) and type II alveolar 
epithelial cells (DeMaio et al., 2012). However, due to the constitutive expression of 
the Cre construct, the possibility that these lineages arise from a population 
expressing NKX2-1 at any stage of development and not as part of the primordium 
cannot be excluded.  
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Another project, also using the Nkx2-1Cre recombinase mouse, in a cross to a 
floxed-ROSA26LacZ mouse, demonstrated efficient labeling through the entirety of 
the epithelium.  However, due to the transgenic nature of the construct, the reporter 
did not accurately mimic the expression kinetic of the endogenous Nkx2-1 gene and 
turned on between E10.5 and E11.5, well after the primordial stage demonstrating it 
was not a useful tool for labeling the specification-stage population (Christodoulou, 
2011). Taken together, these studies indicate a gap in our knowledge of early lung 
development. To this end, we have designed and tested a mouse model for the 
specific labeling of the early lung primordium.  
 
Results 
Nkx2-1CreERT2 x ROSAnT-nG mouse cross  
To enact labeling specific to the earliest stage of specification, we generated a 
mouse cross using the Nkx2-1CreERT2  mouse (Taniguchi et al., 2011) crossed with the 
ROSAnT-nG reporter mouse (Prigge et al., 2013) (Figure a1.1B). This system uses the 
tamoxifen inducible Cre allele to generate nuclear targeted green fluorescence. The 
nT-nG construct, expresses a constitutive red (tdTomato) fluorophore which is 
excised following Cre-mediated recombination. The excision of the nT allele then 
initiates expression of the green (eGFP) fluorophore. In this dual reporter system, 
recently labeled cells will shortly express both fluorophores, adding a temporal 
layer of control. We selected the nuclear-targeted (nT-nG) reporter construct over 
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the similar membrane-targeted (mT-mG) reporter construct to facilitate 
quantification analysis.  
 
Efficient labeling of primordial NKX2-1+ population 
After testing several dosages of tamoxifen and variations on the number and 
timing of treatments, we concluded that dual tamoxifen injections, E7.5 and E8, 
were sufficient to label the majority of the lung epithelium (Figure a1.1C-E). A co-
stain with the epithelial marker EpCAM revealed labeling exclusively localized to the 
epithelium at E14.5. 
To explore the potential analyses based on quantification or relative gene 
expression analysis, we tested the utility of EpCAM as a marker for the purification 
of lung epithelial populations. We found that sorting, using adult Nkx2-1GFP mouse 
lungs, gated on EpCAM staining (Figure a1.2A,B) is a successful method of purifying 
lung epithelial populations. Gene expression analysis using a panel of probes 
indicative of specific lung lineages demonstrated high relative enrichment in the 
EpCAM+ fraction (Figure a1.2C). 
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Figure a1.1 Mouse model for lineage tracing of the NKX2-1+ lung primordium 
A. Time course from the Nkx2-1GFP reporter mouse showing the developmental progression of the 
NKX2-1+ lung. Images acquired by Laertis Ikonomou. 
B. Schematic of the mouse strains crossed for subsequent experiments. 
C. Experimental schematic of treatment and analysis timeline. 
D. Whole lung imaging at E14.5. 
E. Imaging of sections (E14.5) stained with the epithelial marker EpCAM. 
 
 
 
 
 
 
Figure a1.2. EpCAM sort purifies the lung epithelium. 
A. Experimental schematic for B,C. 
B. Sort Schematic: Adult Nkx2-1GFP mouse lung digestion with EpCAM stain. 
C. Gene expression of lung lineage markers in the sorted fractions from (B). Scale represents the 
fold change normalized to the unsorted (pre-sort) lung digest.  
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Ongoing and future experiments 
After establishing the efficient experimental parameters to lineage trace the 
lung epithelium, the next step is to repeat the tamoxifen injections and analyze pups 
at three weeks post-natally for lineage-specific analysis. This time point is after the 
final stages of lung development and all the mature lineages have been established. 
Ideally four replicates from separate litters will be analyzed. Immunostaining and 
imaging will compose the majority of the analysis. Lung sections will be stained for 
lineage-specific markers (Table A1.1) and analyzed for overlap with lineage-labeled 
green (nG expressing) cells. Additionally, lungs from other littermates can be sorted 
based on EpCAM and green labeling, and analyzed for proportional gene expression 
of lineage markers within the EpCAM+, nT+/- populations as a confirmatory 
experiment.  
Lung Lineage Marker(s) 
AECI PDPN, HOPX 
AECII  SPA, SPB, SPC 
Basal P63 
Goblet MUC5AC 
Club CC10 
Ciliated FOXJ1 
Neuroendocrine ASCL1, CGRP 
 
Table a1.1. Markers for the identification of differentiated lung lineages. 
  
  151 
Discussion 
 
Expected results should fall into one of two categories. Robust lineage tracing 
overlapping with downstream marker analysis will confirm the hypothesis of the 
field, that the lung primordium gives rise to the entirety of the lung epithelium. 
Conversely, if specific lineages are excluded or heavily under-represented from the 
trace, it will open the possibility that there are other contributing populations 
remaining NKX2-1- at the primordia stage. In either case, conclusive results will be 
helpful to the field of lung development.  
Current progress in the in vitro differentiation of lung lineages supports the 
hypothesis of the primordial origins. Protocols developed for the derivation of 
specific lung lineages have demonstrated success through targeting differentiation 
into NKX2-1+ lung progenitors preceding subsequent lineage-specific differentiation 
and maturation (Hawkins et al., 2017; McCauley et al., 2017).  
The experimental schematic from this project can be applied to other models 
as well. One such prospective project seeks to analyze the plasticity of the 
developing lung at early stages using a conditional ablation model (Illustration 
A1.1). Preliminary results using the Nkx2-1CreERT2; ROSAnt/ng cross have 
demonstrating the percentage of labeling can be modulating in a dosage-dependent 
manner. Performing parallel experiments using a similar Nkx2-1CreERT2; ROSADTA 
mouse cross to drive conditional cell ablation by diphtheria toxin expression would 
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examine the ability of the lung to compensate for early injury that reduces the size 
of the progenitor pool.  
 
  
 
 
 
 
 
 
Illustration a1.1. Experimental schematic for the conditional lung progenitor ablation model.  
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